Research Authority - Technion R&D Foundation

Active Funding Resources: Full list

Sub-lists: Life | Exact and Material | Soc & Humanities

For any assistance call Robi – 2152, robertg@technion.ac.il or Michal - 1745, MichalL@trdf.technion.ac.il

The list is arranged by deadlines chronological order (dd.mm), first Israeli, then Foreign

 

Israeli: 

 

29.4 | Water Authority: Research Grants in Water issues - Pre-proposals (IN HEBREW) (Application approved for the preliminary stage)

Grants in amount of approx. 350,000 NIS over 3 years will be awarded in the following topics (for detailed topics see the RFP):

- Desalination and desalination technologies

- Water quality and wastewater treatment

- Water security and safety

- Hydrology of ground and runoff water

- Climate, climate changes, hydrometeorology and rain

- Economy and water use optimization

- The Kinneret lake

- Planning, management and regulation in the water sector

http://www.water.gov.il/Hebrew/ProfessionalInfoAndData/Studies/Pages/kolkore-2014.aspx

 

30.4 | Ministry of Agriculture Chief Scientist & China MOST: Agriculture Collaborative Research

Call for collaborative research proposals in the following topics:

1. Sustainable agriculture and natural resource management.

2. Development of new cultivars of wheat and field crops tolerant to stress and drought by conventional and biotechnological approaches.

3. Physiology of agricultural products in the adaptation to climate changes.

4. Dairy farming and dairy technology.

Funding: $1M for 3 years for Israeli side, $2M in total for both sides.

http://www.science.moag.gov.il/framekolkore.html

http://most.gov.cn/tztg/201401/t20140129_111752.htm

 

30.4 | MOST: China-Israel Joint Research in Renewable Energy and Bio-Medical Engineering

Call for cooperative research in the following areas:

1. Material Science and Engineering for Clean and Renewable Energy

2. Bio-Nano Technology and Bio-Medical Engineering

Funding: $100,000 for each side over 2 year period. About 10 projects are anticipated to be funded.

http://most.gov.il/Information/Calls/Pages/Material-Science-and-Engineering.aspx

 

1.5 | BSF-NSF: Joint funding Program in Brain Science (EAGER Program) - brain function underlying behavioral and cognitive processes – pre-proposals (Deadlines: NSF-1.5, BSF-7.5)

A new joint funding program with the Integrative Organismal Systems (IOS) and Biological Infrastructure (DBI) divisions in the Biological Sciences Directorate of the NSF in brain research.

1. The program will award Early Concept Grants for Exploratory Research proposals with the potential to transform our ability to analyze brain function underlying behavioral and cognitive processes. The interest is in highly innovative projects in their early stages that utilize new and untested, but potentially ground-breaking approaches, and neurotechnologies that bridge multiple spatial, temporal, and organizational scales to provide fundamental insights into the emergent properties of neural circuitry that ultimately lead to behavior and cognition. These high impact short-term projects must transcend approaches typically supported by the core research programs at NSF and BSF.

2. In this first stage of the program, US PIs will submit a two page summary of their research ideas, and can team up with an Israeli PI. Selected applicants will be invited to submit full proposals. In a later stage it may be possible to submit proposals for longer research projects with greater funding. However, there is no certainty that these additional stages in the program will take place.

3. Although the NSF accepts applications only from US scientists, in all stages of the program, the role of the Israeli must be stated and it should be clearly explained why his contribution is essential.

4. If awarded, the US PI will receive a grant from the NSF, while the Israeli PI will receive a grant from the BSF. The funding amount to the Israelis is expected to be $100,000 over two years.

An Israeli PI will be allowed to hold both a grant in a BSF-NSF program and a grant in the regular BSF program, unless the projects are similar.  Proposals will be evaluated by the NSF, using its criteria, while the BSF may take part in the evaluation process in the full proposal stage.

Submission: 1. Applications of both summaries (pre-proposals) and full proposals will be made by the US PI to the NSF using its regulations and submission system and by both the Israeli and the US PIs to the BSF, using its regulations and submission system.

Timetable: Two pages summaries (pre-proposals) will be submitted to the BSF by 5 pm (Israel time) on May 7. NSF deadline is May 1, 2014.

CFP: http://www.bsf.org.il/data/FormsToDownload/BSF-NSF_Brain_Science_Program_Call_for_Proposal.pdf

BSF submission instructions: http://www.bsf.org.il/ElectronicSubmission/GatewayFormsAndGuidelines.aspx ('Pre-proposal BSF-NSF Brain Research')

NSF details: http://www.nsf.gov/pubs/2014/nsf14044/nsf14044.jsp

 

1.5 | University of Haifa Press – 2014 Bahat Prize for outstanding academic manuscripts

הוצאת הספרים של אוניברסיטת חיפה: פרס בהט לשנת תשע"ד 2014 לספר העיון המקורי הטוב

פרס לכתב-יד עיוני, מקורי ואיכותי, בשפה העברית אשר לא פורסם בבמות אחרות, ואשר יש בו עניין לציבור הרחב. הפרס בגובה 140,000 ₪ יחולק בין 4 זוכים.

http://press2.haifa.ac.il/index.php?option=com_content&view=article&id=2&Itemid=3

 

8.5 | BIRAX: Britain-Israel collaboration in Regenerative Medicine - Preliminary Proposals

BIRAX Regenerative Medicine Initiative will fund ground-breaking research that:

1. Explores the use of stem cell technology and tissue engineering in the context of fundamental disease processes;

2. Discovers new mechanisms that might be targeted to develop novel regenerative therapies; or

3. Advances understanding of stem cell biology, using lessons learnt from developing tissues and organs, or the mechanisms underlying cell fate and the principles of cellular pluripotency for the development of stem cell-based therapies.

BIRAX will fund collaborations in a wide spectrum of approaches, including biological, chemical and material sciences relevant to Regenerative Medicine, and both basic and translational research. Funding: £400K / 3 years. About 7 projects will be funded.

Call for specific proposals: In addition to this general call we welcome research proposals with particular focus on cardiovascular diseases, Type-1 diabetes and neurodegenerative conditions as set out below. Proposals in these areas may receive funding - wholly or partially – from one of our partners. Applications in these areas may benefit from discussing the research priorities of our partners.

Cardiovascular disease: The application of regenerative therapies toward the diagnosis and treatment of cardiovascular disease. We welcome research in the class of diseases that involve the heart, the blood vessels or both. Funding for this strand may come from the British Heart Foundation. See their priorities at www.bhf.org.uk

Type 1 Diabetes: Regeneration of beta cells and the prevention of their immune-mediated destruction, maintaining the survival of extant and newly generated beta cells. Funding for this strand may come from JDRF. See their priorities at www.jdrf.org.

Neurodegenerative conditions: 1- The role of stem cell technology in understanding fundamental neurodegenerative processes; 2- New mechanisms targeted at developing novel therapies for diseases such as Alzheimer’s, Multiple Sclerosis, and Parkinson’s Disease. Funding for this strand may come from Alzheimer’s Research UK and Parkinson’s UK. See their priorities at www.alzheimersresearchuk.org / www.parkinsons.org.uk .

http://www.britishcouncil.org.il/en/programmes/science/birax/call-proposals

http://www.britishcouncil.org.il/sites/britishcouncil.il/files/birax_second_call.pdf

* Registrations are accepted for the Q&A webinars on 24 April. Please email  biraxrmi@britishcouncil.org.il

 

BIRAX provides also a Fellowship Scheme that supports research visits by UK and Israel researchers for up to 6 months to laboratories in the UK and Israel. This program is open to PhD students, Post-Docs, young researchers and others in the field of Regenerative Medicine. Applications are accepted on a rolling basis. The next date for assessment will be in June.

http://www.britishcouncil.org.il/en/programmes/science/birax/fellowship-scheme

 

10.5 | Ministry of Agriculture: Poultry research 2015 - pre-proposals

משרד החקלאות, שירות ההדרכה והמקצוע, אגף בעלי חיים: הצעות למחקר בענף העופות לשנת 2015

המשרד מבקש הצעות מקדמיות למחקר או לניסוי שדה בתקציב של עד 100,000 ש"ח לשנה, בהתאם ליעדים לשנה זו:

בחינה וטיפול באיומים מיידיים

מזעור פחתים

שימור איכות הסביבה

רווחת העוף

ייעול הייצור

בריאות העוף

*** קובץ***

 

15.5 | MOST Italy-Israel: Renewable energy for sustainable living

Joint Israel Italy teams are invited to submit joint proposals. Funding: up to € 66,000 for each side over 2 yrs. About 6 projects will be funded.

http://most.gov.il/Information/Calls/Pages/Colab_Italy.aspx

 

15.5 | MOST: Italy-Israel joint research in Restoring, Preserving, Valuing and Managing Cultural Heritage

Cultural heritage is at risk due to the passage of time, environmental degradation, climate change, urbanization, pollution, negligence, tourism, vandalism, stealing of artworks and wars.  Italian-Israeli research teams are invited to submit joint research proposals that are aimed at developing countermeasures for restoring, preserving and managing cultural heritage.  Funding: up to € 66K / for each side over 2 yrs. About 6 projects will be funded.

http://most.gov.il/Information/Calls/Pages/Colab_Italy.aspx

 

 

15.5 | Israeli Dairy Board: Call for proposals for research programs in dairy cattle for 2015 – Pre-proposal

מועצת החלב: קול קורא להגשת תוכניות מחקר מקדמיות לשנת 2015

הזמנה להגיש הצעות מחקר בתחומים הבאים:

- שיפור ריווחת בעלי חיים.

- שמירה על איכות הסביבה בדגש על הטיפול בשפכים וזבל.

- פיתוח מבני רפת המותאמים לרווחת בעלי חיים ולשמירה על הסביבה.

- ייעול ההזנה ושיפור הפוריות באמצעים תזונתיים וממשקיים.

- פיתוח כלים להתמודדות בפני מחלות זיהומיות בעדיפות לאלו המועברות ע"י פרוקי רגליים

גובה מימון לא מצויין.

http://www.halavi.org.il/info/research/main.htm

 

16.5 | Ministry of Defense / MAFA’T: Research ideas for development of new technologies for use by the military

משרד הביטחון/מפ"את: קול קורא לשנת 2014 למחקרים עבור מערכת הביטחון

הצעות לרעיונות ומחקרים שיתרמו לפיתוח אמל"ח ותשתיות טכנולוגיות עבור מערכת הביטחון. דוגמאות לתחומי עניין (לא מוגבל רק לתחומים אלה):

- תשתית טכנולוגית לטובת החייל

- טכנולוגיות מידע כולל אבטחת מידע

- ראייה ממוחשבת

- מיגון

- רובוטיקה ומערכות אוטונומיות

 -אווירודינמיקה

- חומרים

- מבנים חכמים

- טכנולוגיות קוונטים בעיקר לטובת חישה רגישה

- יישומים במדעי החיים לטובת מערכת הבטחון

- הנדסת אנוש וממשק מח-מכונה

- מערכות הספק גבוה, כולל Pulsed power

- קוגניציה

- ננוטכנולוגיה כולל ננו חומרים ומטא-חומרים

- אקוסטיקה

- אנרגיה מכוונת

- מערכות אנרגיה

- RF - פוטוניקה

- בעלי חיים

- רפואה צבאית

- פסיכולוגיה

- חומרים אנרגטיים

- חיישנים וטכנולוגיות חישה

- סימולטורים ומתקני תשתית

מימון: 200,000 ₪ לשנה, עם אפשרות הארכה לשנה אחת נוספת.

http://tx.technion.ac.il/~research/Defense_MAFAT_2014.pdf

http://tx.technion.ac.il/~research/Defense_MAFAT_2014_Suppl.docx

 

29.5 | MOST: India-Israel Scientific Research Cooperation in Energy Engineering

Indian-Israeli joint research proposals are solicited in the following topics:

Mechanical Engineering - Generation/production of renewable fuels for transportation.

Chemical Engineering - Chemical processes and biotechnological aspects of renewable energy production.

Material Engineering – Energy Storage/renewable energy

Total funding amount for the 2 years program is $420K for the Israeli side and up to 7 projects will be funded (approx.$30K/year for the Israeli side and approx. Rs.15 lakhs/year for the Indian side).

http://most.gov.il/Information/Calls/Pages/IndiaCall.aspx

 

29.5 | Ministry of Infrastructure, Energy and Water: Projects in the field of Energy and Land & Oceanography 2014

משרד התשתיות, האנרגיה והמים: קול קורא למחקרים בתחום האנרגיה ומדעי האדמה והים לשנת 2014

ניתן להגיש הצעות בתחומים (פירוט נוסף בנספח ב' לקול הקורא):

- אנרגיות חלופיות, התייעלות אנרגטית ושימור אנרגיה

- מים ואנרגיה

- דלקים פוסיליים

- כרייה וחציבה

- היבטים סביבתיים הקשורים לניצול משאבי טבע

- רעידות אדמה וסיכונים סיסמיים

- מחקרים בנושאי מדיניות וכלכלת משאבים

- תחנות כוח גרעיניות

- מחקרים בשת"פ בינלאומי של המשרד

גובה מימון מירבי לא מצויין. תקופת המחקר: עד 3 שנים

http://energy.gov.il/Subjects/RAndDChiefScientist/CallForProposals/Pages/GxmsMniTender4_14.aspx

 

1.6 | PAZI Fund (Israel Atomic Energy Commission): Call for Workshops and Conferences

קרן פזי: קול קורא לסדנאות וכנסים

תמיכה בסדנאות ובכנסים בנושאים הקשורים לנושאי המחקר הממומנים על ידי הקרן במטרה להיות השלמה למחקרים, לעודד קשרי מחקר בין מדענים מהארץ ומחו"ל ולהוות פלטפורמה לדיונים מדעיים. מימון עד 100,000 .

http://www.technion.ac.il/~research/PAZI.pdf 

 

2.6 | Ministry of Environmental Protection Chief Scientist: Call for Establishment of a National Research Center for the Study of Materials, Waste, Recycling and Reclamation

 

המשרד להגנת הסביבה לשכת המדענית הראשית: קול קורא להקמת מרכז מחקר לאומי לחקר חומרים, פסולות, מחזור והשבה

נושא הגשת ההצעות כעת בדיון אצל ראשי האוניברסיטאות בשל תנאי המימון שאינם מקובלים. הצעות יוגשו רק אם תנאי המימון ישונו לשביעות רצונן של האוניברסיטאות. המעוניינים מתבקשים להתעדכן ברשות המחקר.

על מנת לצמצם את פערי הידע, לקדם את תחום המחקר ולאתר פתרונות טכנולוגיים-כלכליים עסקיים בתחומים של התייעלות ושימושים פורצי דרך בחומרי גלם בבניית מוצרים, מחזור והפקת אנרגיה, טיפול חדשני בפסולת עירונית, חקלאית ותעשייתית (להוציא פסולת תעשייתית מסוכנת, טיפול בשפכים במתקני טיפול וטיפול בבוצות(. המרכז יבצע פעילויות שונות כדלקמן: ביצוע מחקר בסיסי ויישומי, פיתוח קורסים ופעילות הוראה, ייזום כנסים, ימי עיון וסדנאות ופרסום חומרים.

המרכז יכלול לפחות 20 חוקרים, לפחות 5 מהם חוקרים חדשים מלפחות 3 מוסדות אקדמיים שונים. כל חוקר וכל מוסד יכולים להשתתף בהצעה אחת בלבד. המרכז יפעל לתקופה של 5 שנים לפחות, אך מצופה להגיש כחלק מההצעה תכנית כלכלית לקיומו העצמאי מעבר לתקופה זו. לתכנית זו יינתן משקל בבחירת ההצעה הזוכה.

מודל המימון של מרכז המחקר יהיה מודל של 1/3-2/3 כאשר מתן התמורה של המשרד יעמוד על שני שליש מסך תקציב המרכז ותקצוב המוסדות יעמוד על שליש ממנו. סך היקף מתן התמורה מאת המשרד במהלך 5 השנים הראשונות בלבד לא יעלה על סך של  40מיליון ₪, כאשר התמורה השנתית המקסימלית תעמוד על 8 מיליון ש"ח לשנה.

http://www.sviva.gov.il/subjectsenv/envinfo/pages/research-center.aspx

 

10.6 | MOST: France-Israel Cooperation in: Agriculture under stress  /  Personalized medicine

French-Israeli joint research proposals are solicited in the following topics:

1. “Agriculture under stress"

2. "Novel approaches and tailored therapeutic agents in personalized medicine"

Funding: Total funding for the research programs is 500K for each side for the 2–year duration. Up to 6 projects will be funded (approx.40K/year for each side).

http://www.campusfrance.org/fr/appels-a-candidatures

http://www.campusfrance.org/sites/default/files/maimonide.pdf

http://most.gov.il/Information/Calls/Pages/default.aspx

 

12.6 | Ministry of Defense and Heil Refuah: 2015 Medical Research Grants – Pre Proposal

משרד הביטחון וחיל הרפואה: מענקים למחקרים בתחום הרפואה הצבאית לשנת 2015 – הצעות מקדמיות

תחומי המחקר (פירוט נוסף בקישור המצורף):

- רפואה מבצעית: מניעת תמותת פצועים ברי הצלה, מניעה ומזעור פציעה קרבית

- רפואת הלוחם: מניעה, אבחון וטיפול של פציעה שאינה קרבית ושיפור המוכנות והתפקוד בלחימה באויר בים וביבשה ומצבי קיצון

- בריאות וכשירות החייל: שיפור הכשירות הפיזית והנפשית לביצוע המשימה ומניעת תחלואה ייחודית (זיהומית, תעסוקתית וסביבתית)

מימון: עד 100 אלף ₪ לשנה עם אפשרות להארכה.

http://www.refua.atal.idf.il/1638-he/Refuah.aspx

 

12.6 | Ministry of Environmental Protection Chief Scientist: Call for Research Proposals

המשרד להגנת הסביבה לשכת המדענית הראשית קול קורא בנושאים:

במסגרת פניה זו ניתן להגיש הצעות למחקרים מדעיים, סקרים או סקרי התכנות בנושאים המפורטים בלבד.

על ההצעות להיכתב בשפה העברית , החלק המדעי בלבד של ההצעה יכול להיכתב בשפה האנגלית.

שימו לב- חוקרים המעוניינים להגיש הצעות עם שותפים, צריכים להמציא אישור התחייבות על השותפות מהמוסד השותף.

הפקת אנרגיה מביומסה

1. הפקת דלק מאשפה עירונית אורגנית

2. הפקת דלק מפסולת בעלי חיים (בקר, עופות, כבשים ואחרים)

3. הפקת דלק מפסולת צמחית (פסולת חקלאית, גזם, עודפי יבול, עודפי בתי אריזה)

4. הפקת אנרגיה (או דלק) משפכים תעשייתיים בעלי ריכוזים נמוכים יחסית של חומר אורגני (עד 10,000 מג"ל צח"כ COD)

השבת הפסולת / השפכים תשמש לאנרגיה ודלקים מסוגים שונים כביוגז, סינגז, ביודיזל או סוגי דלק אחרים המתאימים לשימוש בתעשיה, בתחבורה או לטיוב קרקעות.

במסגרת זו ניתן להגיש הצעות למחקרים מדעיים בעלי פוטנציאל לישימות מסחרית.

משך המחקר המוצע עד 3 שנים ועלותו המבוקשת עד 450,000 ₪. התקציב הכולל לתוכנית זו הנו 1.155 מיליון ₪.

מחקרים בנושא תחליפי נפט לתחבורה

-הערכת אומדן הפחת בגז טבעי בשרשרת האספקה מהבאר לרכב (Well to wheel), בחינת ההשפעה הסביבתית ודרכי התמודדות.

-ניתוח מחזור חיים- Life Cycle Analysis - להתקני אחסון אנרגיה, מצברים, סופר קבלים, תאי דלק והנעות חלופיות.

-בחינת הסיכונים של חניית רכבים מונעי גז טבעי בחניונים.

-השפעת תחליפי דלקים לתחבורה על ריאקטיביות אטמוספרית שניונית (יצירת אוזון למשל), אל מול דלקים קונבנציונאליים.

-בחינה השוואתית של חלופות ללכידת CO2 בתהליכי יצירת דלקים מגז טבעי.

-תנאים סביבתיים למפעלי ייצור מתנול ודלקים סינטטיים מגז טבעי, במטרה של מניעה וצמצום ההשפעות הסביבתיות (פליטות לאויר, זיהום קרקע, שפכים וכו').

-חקירת ההשלכות הסביבתיות של תחליף הנפט לתחבורה כולל שימוש יעיל במשאבי טבע.

-השלכות סביבתיות של מתקני הפקה, עיבוד, אחסון, הולכה וחלוקה של תחליפי נפט לתחבורה.

-רגולציה סביבתית וסטנדרטיזציה של תחליפי נפט לתחבורה.

משך המחקר המוצע עד 3 שנים ועלותו המבוקשת עד 200,000 ₪. התקציב הכולל לתוכנית זו הנו 1.7 מיליון ₪.

http://www.sviva.gov.il/subjectsEnv/EnvInfo/KolKore2014/Pages/default.aspx

 

2.9 | ISF: Publication support in the fields of Humanities, Anthropology and Political Science

הקרן הלאומית למדע: התכנית לסיוע בתקציב הוצאה לאור של ספרים שהם פירות של מחקר בתחומים של מדעי הרוח, אנתרופולוגיה ומדע המדינה.

התכנית מיועדת לסייע בהוצאה לאור של חיבורים שהם פירות של מחקר מדעי במדעי הרוח, מחקר בינתחומי הגובל במדעי הרוח ומחקר תרבות, ניתוח שיח ותקשורת עם דגש איכותני. עבור חיבורים שאינם בתחום מדעי הרוח באופן מובהק אך כלולים בתכנית (כמתואר לעיל) יש לקבל מראש את אישור מנהלת התחום.

גובה המענק: 50% מהתקציב להוצאת ספר, עד 100% מההוצאות במקרה של תרגום / עריכה.

http://www.isf.org.il/applications_guidlines.asp

 

16.9 | US-Israel Binational Agricultural Research and Development Fund (BARD): US-Israel Agriculture research

BARD projects, conducted cooperatively by US and Israeli scientists, cover all phases of agricultural research and development. Funding: Up to $340,000 for 3 years. One year feasibility studies are also accepted. Research areas that were identified as top priorities for the coming years:

• Increased Efficiency of Agricultural Production;

• Protection of Plants and Animals Against Biotic and Abiotic Stress;

• Agricultural Production Challenges in Increasing Marginal Conditions

• Food Quality, Safety and Security;

• Water Quality & Quantity;

• Functional Genomics and Proteomics;

• Sensors and Robotics;

• Sustainable Bio-Energy Systems;

http://www.bard-isus.com

 

1.10 | DFG: Trilateral German-Israeli-Palestinian Cooperation - Preliminary proposals

The program supports peaceful development in the Middle East (all fields). In appropriate cases it is possible for a partner from another of Israel’s neighbor countries to participate in a project, either instead of, or in addition to, the Palestinian partner. The DFG funds the project expenses for all three partners. The German funding recipient is responsible for forwarding the funds to the Israeli and Palestinian partners in accordance with the award. Funding: up to 5 years (with a 2-year initial phase). The average amount for all groups would be €150K - €200K / year.

http://www.dfg.de/en/research_funding/programmes/international_cooperation/trilateral_projects/in_brief/

 

28.10 | BSF: NSF-BSF Collaborative Research in Computational Neuroscience (CRCNS)

Information from last years' call, details will be updated when current call is published

Applications must involve a computational aspect, but can also involve empirical work. Research projects must be grounded in Biology (as opposed, e.g., to studies pertaining only to artificial neural networks) and must clearly demonstrate the added value of the cooperation between the partners. The competition is open to neuroscientists and other scientists who are not classical computational neuroscientists if they are engaged in appropriate collaborations and their study is relevant to the program. Applications must be submitted jointly by an Israeli and an American scientist from a U.S. research institution to BSF, in parallel, the U.S scientist should submit (alone) an application to the NSF. Adding a scientist from a third country is not allowed. The program is managed by the NSF, but is joined also by the NIH and if awarded, the U.S. scientist will receive a grant from the NSF, or the NIH, while the Israeli scientist will receive a grant from the BSF. Funding: up to $200,000 over 3-4 years for the Israeli side.

http://www.bsf.org.il/data/FormsToDownload/BSF-NSF_Computational_Neuroscience_Program_Call_for_Proposal.pdf

http://www.bsf.org.il/ElectronicSubmission/GatewayFormsAndGuidelines.aspx

http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5147&org=IIS

 

31.12.14 | Ministry of Energy and Water: Conferences, Seminars and exhibitions

משרד האנרגיה והמים: קול קורא להצעות להשתתפות המשרד בכנסים, ימי עיון ותערוכות

המשרד מזמין בזה להציע הצעות להשתתפותו בכנסים, ימי עיון ותערוכות, בתחומים הבאים:

א. בנושאי האנרגיה בכלל ובתחום האנרגיות המתחדשות בפרט.

ב. בנושאי דלקים וביניהם בין היתר, תחליפי דלקים לתחבורה, לייצור חשמל, גפ"מ ועוד.

ג. בנושאי הגז הטבעי, ובניהם בין היתר, LNG,CNG, GTL  תעשיות מבוססות גז טבעי ועוד.

ד. בנושאי משק החשמל הרלוונטיים לעבודת המשרד.

ה. בנושאי התייעלות אנרגטית.

ו. בנושאי חיפושי נפט וגז טבעי.

ז. בנושאי מדעי הים והאדמה.

ח. כל כנס או יום עיון אחר, הקשור במישרין או בעקיפין לפעולות המשרד, ויש בעצם הסיוע לו בכדי לתרום להתפתחות וקידום התחום.

המשרד לא ישתתף כספית בכנס, יום עיון או תערוכה, בסכום העולה על 100,000 ₪, מלבד מקרים חריגים שיקבלו את אישור ועדת המכרזים של המשרד, מנימוקים מיוחדים שירשמו.

http://energy.gov.il/InformationForPublic/tenders/Pages/GxmsMniTender44_13.aspx

 

Israeli - all year round:

 

Israel Anti-Drug Authority: Research Grants

Research in medical, behavioral and other fields related to drug and Alcohol addiction.

www.antidrugs.gov.il/template/default.aspx?catid=44

 

Israel Insurance Association Research Fund: Research Grants

The Fund welcomes applications for financial support for the purpose of conducting research on insurance matters, especially on the subject of motor bodily injury insurance, and other insurance branches of importance to the public interest (i.e Earthquake and other Natural hazards risks and insurance). Funding: ask the Research Authority - 2152

Eng: www.igudbit.org.il/eng/Index.asp?CategoryID=451

Heb: www.igudbit.org.il/Index.asp?CategoryID=420

Guidelines and form: www.igudbit.org.il/_Uploads/1616keren(1).doc

 

Israel Insurance Association Research Fund: Research Grants on Natural Hazards - Earthquakes / Sinkholes

The Fund issued a call for proposal dedicated to applied research on the following:

-Possible Earthquake in Israel and its implications;

-Sinkholes in the Dead Sea region;

Funding: the call specifies approximate amount of hundreds of thousands NIS over up to 3 years.

Detailed info.

 

MOST - BMBF: German-Israeli Cooperation in Water Technology - Young Scientists Exchange Program

In order to encourage young scientists to engage themselves in the Water Technology Research Program in the framework of the German-Israeli Cooperation, BMBF and MOST have initiated a young scientists exchange program. The program is open to Israeli and German diploma/M.Sc.-students, post graduates, doctoral degree students, and post doctorates candidates who wish to spend a training period in Israel or Germany for 1-6 months. Candidates are considered “Young Scientist” if no more than 3 years have passed since receiving the PhD.

http://most.gov.il/Information/Calls/Pages/kkmadaei-hayamim.aspx

 

The Israel Securities Authority (ISA) (HA'RASHUT LE'NIAROT ERECH): Research Grants

Research grants in amount of 5,000-40,000 NIS in subjects relevant to ISA activity.  

http://www.isa.gov.il/Download/IsaFile_4100.pdf

 

Britain - Israel Research and Academic Exchange (BIRAX) Regenerative Medicine Initiative: Short Term Fellowship Scheme

Supports research visits by UK and Israel researchers for up to six months to laboratories in the UK and Israel. It is an opportunity for researchers to establish or strengthen research links and to facilitate collaboration between the home and host research groups. ‘Early’ career researchers as PhD students and Post Docs are especially encouraged to apply, but not exclusively. The fields of research to be supported in the framework include but are not restricted to:

1. Developmental biology related to regenerative medicine

2. Stem cell biology related to cell therapy

3. Development of diverse Cell Therapy approaches

4. Tissue Engineering and Biomedical Engineering

5. Use of novel gene replacement technologies for therapeutic purposes

6. Endogenous Repair – stimulating self-repair mechanisms to promote cell or tissue regeneration

Funding: £2,100 per month plus £550 travel allowance. Fellowship period ranges btw. 1-6 months.

http://www.britishcouncil.org.il/en/programmes/science/birax/fellowship-scheme

 

 

Foreign:

 

25.4 | Association for International Cancer Research, UK (AICR): Research Grants

AICR awards project grants to support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. Applications that include some clinical research in a project which is mostly basic or translational may be considered. Funding: no formal upper limit, if budget more than £200,000 (over 3 years) is needed, it is recommended to contact head of science (helen.rippon@aicr.org.uk).

http://www.aicr.org.uk/applyingforagrant.stm

 

27.4 | National Marfan Foundation: Faculty Grant Program

Applications are being requested for two-year grants for basic or clinical research.  The grant program is designed to provide financial support for faculty studying any or all disciplines involved in Marfan syndrome and related disorders.  Funding:  $100K over 2 years.

http://www.marfan.org/nm-cma-faculty-grant

 

29.4 | Spencer Foundation: Education Research Major Grants - Preliminary Proposals

Funding: $50,000- $350,000 for one of the following topics:

* Data Use and Educational Improvement

* Philosophy in Educational Policy and Practice

http://www.spencer.org/content.cfm/how-to-apply-to-the-new-civics-over-50k

 

29.4 | Action on hearing loss (Royal National Institute for Deaf People (RNID)): International Project Grant

The Grant aims to generate scientific discoveries that will lead to new treatments to protect, improve or restore hearing, or to silence tinnitus.

Funding: up to £55,000/year for up to 3 years.

http://www.actiononhearingloss.org.uk/your-hearing/biomedical-research/apply-for-research-grants/our-funding-schemes.aspx

 

30.4 | March of Dimes Foundation (MDF): 2015 Research Program - LOI

Proposals should encompass basic biological processes governing differentiation and development, genetics and genomics of these processes, clinical studies, reproductive health and environmental toxicology, and social and behavioral studies concerning cognitive and behavioral risks that affect outcomes of pregnancy, the perinatal period, and subsequent child development. Applications will be directed to one of three committees whose respective foci are:

• Cell Lineage and Differentiation

• Gene Discovery and Translational Medicine

• Social and Behavioral Sciences. This involves family units and includes genes, toxicants, social determinants that adversely affect language or behavior, especially if involving premature infants or children with birth defects.

Grants are typically awarded for a 3 year period.

http://www.marchofdimes.com/research/researchgrants.html

 

30.4 | American Institute of Ultrasound in Medicine (AIUM): Ultrasound versus Magnetic Resonance Imaging (MRI)

A request for applications to investigate the clinical effectiveness of ultrasound versus magnetic resonance imaging (MRI) for joints or soft tissue pathology using an independent gold standard, either clinical or surgical. Preference will be given to studies other than those addressing rotator cuff tears. $50,000 has been allocated for one or more grants, project should be up to 2 year long.

http://www.aium.org/grants/availableGrants.aspx

 

30.4 | TerumoBCT: Plasma Exchange Innovation Award

Applications may include, but are not limited to: efficacy, mechanism of action, safety and tolerability, quality of life and pharmacoeconomics related to plasma exchange. The novelty of an application is important. The Expression of Interest should call out the importance of the proposal and the potential impact on patient care. Funding: $100K to one recipient or smaller grants (totaling up to $100,000) to multiple recipients.

http://plasmaexchangegrant.com/award.html

 

30.4 | Swiss Bridge Award 2014: Immunotherapy in Oncology – LOI

Projects focusing on "Immunotherapy in Oncology" are eligible for funding.

Funding: up to 500K Swiss Francs

http://www.swissbridge.ch/call-for-application.html

 

1.5 | International Society for Fish Biology (FSBI): RESEARCH GRANTS

Aims to encourage, promote and support all branches of fish biology, fisheries management and fisheries science and conservation. Provides financial support for carrying out research on any topic that is relevant to the Society's objectives.

The Small Research Grant scheme is open to bids for up to £5000 per project. Total annual budget is £30,000.

The Wyn Wheeler Research Grant Fund:  For retired researchers to continue their activity in fish biology. Open to bids for up to £6000 per project. One project will be funded.

http://www.fsbi.org.uk/grants/research-grants/

 

1.5 | Wenner-Gren Foundation: Anthropological research

Post-Ph.D. Research Grants: awarded to individuals holding a Ph.D. or equivalent degree to support individual research projects. Support for basic research in anthropology without preference for any methodology, research location, or subfield. The Foundation particularly welcomes proposals that employ a comparative perspective, can generate innovative approaches or ideas, and/or integrate two or more subfields. Funding: up to $20K.

http://www.wennergren.org/programs/post-phd-research-grants

Hunt Postdoctoral Fellowships: support the writing-up of already completed research. The fellowship is awarded to scholars in the earlier stages of their careers, when they frequently lack the time and resources to develop their research for publication.  Eligible to apply are scholars with a Ph.D. in hand for no more than ten years (from the application deadline). Funding: up to $40K of financial support for 1 year of continuous full-time writing.

http://www.wennergren.org/programs/hunt-postdoctoral-fellowships

 

1.5 | National Niemann-Pick Disease Foundation

Edward H. Schuchman Research Fellowship: Objective: examining the biology of Acid Sphingomyelinase Deficiency (ASMD; i.e., Types A and B Niemann-Pick Disease). Preference to projects that improve understanding of the biology and pathogenesis of ASMD, projects developing new therapies for ASMD, and for identifying biomarkers to improve diagnosis and monitoring disease progression.  Funding: $100K over 2 years.

Peter G. Pentchev Research Fellowship:  Objective: examining the biology of Niemann-Pick Type C (NPC). Preference to projects developing new therapies for NPC, and translational research projects that improve our understanding of the biology, pathogenesis and potential treatment of NPC. Funding: $100K over 2 years. Applicants  for both programs must be in early career stages.

http://www.nnpdf.org/npresearch_01.html

 

1.5 | Crhon & Colitis Foundation of America: Senior Researc Awards - LOI

Proposal relevant to Inflammatory Bowel Disease (Crohn's disease and/or colitis ulcerative). Funding: $115K over 3 yrs.

http://www.ccfa.org/science-and-professionals/research/grants-fellowships/senior-research-awards.html

 

1.5 | NIH/Center for Drug Evaluation Research & FDA:

Dissolution Methods for Microsphere and Implant Drug Products

The purpose of this study is to investigate dissolution methods for a parenteral sustained release dosage form and to analyze their capability of detecting manufacturing differences, predicting in vivo performance, and evaluate method robustness. Funding: Total of $500K for 2 awards.

http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-14-007.html

Dissolution Methods for Semisolid Ocular Drug Products

The purpose of this study is to investigate dissolution methods for a semisolid ocular dosage form and to analyze their capability of detecting manufacturing differences, predicting in vivo performance, and evaluate method robustness. Funding: Total of $350K for 2 awards.

http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-14-008.html

 

1.5 | Jacques and Gloria Gossweiler Foundation: Neurology Research Grants Program

Research on non-pharmacological treatment of symptoms of Parkinson’s disease and other movement disorders. Studies examining the effects of physical activity, physiotherapy, ergo therapy,and speech therapy as well as on psychological and spiritual approaches, shall be supported. Both small, short-term exploratory studies and more advanced, long-term projects will be supported. Projects submitted by researchers in training will also be supported. Funding: Not specified.

http://www.jggf.ch/en/medical-research/neurology/

 

2.5 | Progeria Research Foundation Research Grants

1. Innovator Awards: 2-year awards of up to $75,000/year to allow an investigator to embark on new lines of investigation, and to produce enough preliminary data to be competitive for longer-term funding.

2. Established Investigator Awards: 3-year awards of up to $100,000/year for senior investigators established either in the field of Progeria or a field that can be directly applied to Progeria.

3. Specialty Awards: for smaller, more technology-driven projects, e.g., sequencing, screening potential drugs, obtaining cell lines (including IPSCs,) and preparation of antibodies. Funding amounts and lengths are flexible.

http://www.progeriaresearch.org/grant_application.html

 

2.5 | Volkswagen Foundation: Experiment! – In search of bold research ideas

The initiative supports daring new research concepts in science and engineering, as well as in the life sciences including behavioural biology and experimental psychology through a fast and small grant scheme. German partner required as PI. Funding: € 100K for 1.5 years.

http://www.volkswagenstiftung.de/en/funding/challenges-for-academia-and-society/experiment.html?tx_itaofundinginitiative_itaofundinginitiativelist%5Bcontroller%5D=FundingInitiative&cHash=29d4f3d9556a5d7f02d3a438b7a91ac7

 

2.5 | US Pharmacopeial Convention Global Scholarship Student Award

The USP Global Fellowship Awards Program promotes research in areas relating to standards for medicines, foods, and dietary supplements and their use. For specific topics see "Research Priorities" in link below. Funding: up to $ 50K.

http://www.usp.org/around-world/global-fellowship-awards-program

 

6.5 | Bill & Melinda Gates Foundation: Grand Challenges Explorations in global health research

One bold idea. That’s all it takes. Grand Challenges Explorations fosters innovation in global health research. The Gates Foundation has committed $100 million to encourage scientists worldwide to expand the pipeline of ideas to fight our greatest health challenges. Initial grants of $100K are awarded two times a year. Successful projects have the opportunity to receive a follow-on grant of up to $1 million. Explorations Round 13 Topics (http://www.grandchallenges.org/Explorations/Pages/TopicsOverview.aspx):

- New Ways of Working Together: Integrating Community-Based Interventions

- Explore New Ways to Measure Fetal and Infant Brain Development

- Innovations in Feedback & Accountability Systems for Agricultural Development   

- Inciting Healthy Behaviors: nudge, leapfrog, disrupt, reach   

- Novel Enabling Tools and Models Supporting the Development of Interventions for Severe Diarrhea and Enteric Dysfunction   

http://www.grandchallenges.org/Explorations/Pages/Introduction.aspx

 

7.5 | Society for Neuroscience: Young Scientists Achievements and Research Awards

These awards recognize students, postdoctoral fellows, and scientists who have received an advanced degree within the past 10 years and who have made significant accomplishments in the field of neuroscience.  Eligibility: If one or more of the following statements apply, you may be eligible for an award:

You are a student of neuroscience currently enrolled in a degree-granting program.

You are a postdoctoral student of neuroscience.

You have recently contributed outstanding research to the field of neuroscience.

You are currently involved in research in an international setting.

You are a neuroscientist who has received an advanced degree within the past 10 years.

http://www.sfn.org/awards-and-funding/individual-prizes-and-fellowships/young-scientists-achievements-and-research

 

7.5 | Society for Neuroscience: Science Education and Outreach

These awards recognize the contributions of educators and advocates and their efforts to promote the field of neuroscience to students and the general public. Eligibility: If one or more of the following statements apply, you may be eligible for an award:

You are actively involved in teaching, training, and/or outreach activities to promote the understanding of neuroscience.

You are members of an SfN chapter who carry out various activities to educate the public about neuroscience.

http://www.sfn.org/awards-and-funding/individual-prizes-and-fellowships/science-education-and-outreach

 

9.5 | JSPS Postdoctoral Fellowship Program for Foreign Researchers in Japan

Opportunity for young (PhD since 2/4/08) postdoctoral researchers to conduct, under the guidance of their hosts, cooperative research with leading research groups in universities and other Japanese institutions. All fields of the humanities, social sciences and natural sciences are included under this program. Fellowships are for 12 or 24 months and must start during 1/9/14-30/11/14. Funding: a round-trip ticket, a settling-in allowance of $2,000 and monthly allowance of $3,678. Applications for this program are submitted by a host researcher in Japan who wishes to host a foreign postdoctoral fellow.

http://www.jsps.go.jp/english/e-fellow/fy2014/appli_long_2014.html

 

12.5 | American Society for Bone and Mineral: Research Grants in Aid Program - LOI

Must be an ASMBR member who submitted a peer-reviewed grant application to a major funding sponsor within the last 15 months and received a full review but was not funded. The goal is to allow the recipient to continue to develop the research and strengthen the proposal for future funding. International members living outside the United States are encouraged to apply Funding: $50K.

http://www.asbmr.org/Grants/Detail.aspx?cid=9f612a9f-f7f6-4a85-9c0d-da0d55715fcc

 

14.5 | Society for Neuroscience: Promotion and Mentoring of Women

These awards honor individuals, both male and female, who have made significant contributions to the advancement of women in neuroscience. Eligibility: If one or more of the following statements apply, you may be eligible for an award:

You have significantly promoted the professional development of women in neuroscience.

You have made outstanding contributions to neuroscience throughout your career.

http://www.sfn.org/awards-and-funding/individual-prizes-and-fellowships/promotion-and-mentoring-of-women-in-neuroscience

 

13.5 | DOD-CDMRP: ALS Research Program - competitive pre-application

- Therapeutic Development Award: Supports preclinical development of therapeutics for ALS. Focus areas include: Development of high-throughput screens and model systems;  Development of pharmacological agents up to Investigational New Drug submission;  Pilot current Good Manufacturing Practices production or formulation/stability studies.  Funding: $1.5M / 3 years.

- Therapeutic Idea Award: Supports early-stage research relative to novel therapeutic development for ALS. Studies should be hypothesis based, but have a clearly defined impact on and relevance to therapeutic development for ALS. Innovation and impact are primary criteria. Preliminary data are not required. Funding: $400K / 2 years.

https://ebrap.org/eBRAP/public/Program.htm

 

13.5 | DOD-CDMRP: Bone Marrow Failure Research Program - competitive pre-application

- Idea Development Award: Supports innovative ideas and high-impact approaches to bone marrow failure research that encompass solid scientific rationale and logical reasoning based on existing knowledge. Emphasis on personnel and research team. Funding: $400K / 3 years.

https://ebrap.org/eBRAP/public/Program.htm

 

14.5 | DOD-CDMRP: Breast Cancer Research Program - competitive pre-application (except for Breakthrough Award Levels 1-2)

- Innovator Award: Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field.  Provides opportunity to pursue novel, visionary, high-risk ideas that will accelerate progress toward ending breast cancer.   PIs must include breast cancer advocates on their research team.  Funding: $5M / 5 years.

- Breakthrough Award Levels 1-2: Investigators at all academic levels (PostDocs are eligible and encouraged to apply, with additional applications components). Supports promising research that has the potential to lead to or make breakthroughs in breast cancer. Potential impact of the research may be near-term or long-term, but it must be significant and go beyond incremental advancement. Partnering PI Option allows 2 PIs to collaborate. Consumer advocate involvement is encouraged, but not required. Letter of Intent is required (non-competitive). Clinical trials are NOT allowed. Funding is for 3 years: Level 1- $350K; Level 2- $700K.

- Breakthrough Award Levels 3-4: Like level 1-2 except these: Only independent investigators are eligible (no PostDocs); Applicants ARE required to include breast cancer advocates on their research team. A (competitive) pre-proposal is required. Clinical trials ARE allowed. Funding is for 5 years: Level 3- $2.5M; Level 4- $10M.

https://ebrap.org/eBRAP/public/Program.htm

 

14.5 | Parkinson's UK: Innovation Grants

Looking for high-risk, high-reward research that could lead to exciting breakthroughs in the causes, treatment and cure of Parkinson's, tackling major scientific or technical hurdles in the field. Funding: £35K for one year. (a second application by Sept.10)

http://www.parkinsons.org.uk/content/innovation-grants

 

15.5 | Juvenile Diabetes Research Foundation (JDRF): Exploratory Clinical Trials to Prevent Progression of Diabetic Nephropathy- LOI

LOIs are sought from investigators with approved or investigational drug candidates to validate mechanism of action and/or efficacy in preventing progression or reversal of diabetic nephropathy in T1D. JDRF is particularly interested in targeting patients with disease no more severe than CKD3 based on NKF definitions, as well as, trials that use novel approaches to stratify entry population based on estimated risk of progression during the trial. Under exceptional circumstances, proposals that also include preclinical studies may be considered if needed to obtain regulatory approval to move forward with the proposed clinical trial. Funding: up to $1 million/yr for up to 3 yrs.

http://jdrf.org/grant-center/grant-opportunities-and-deadlines/

 

15.5 | amfAR, The Foundation for AIDS Research: Krim PostDoc Fellowships in Basic Biomedical HIV/AIDS Research

The goal of Krim Fellowships in Basic Biomedical Research is to: Facilitate the exceptional postdoctoral researcher’s transition to a productive and independent long-term career in HIV/AIDS research; Support 2 years of postdoctoral basic biomedical research (phase I);  Provide the possibility of one additional year of research funding during the first year of an independent research position (phase II). Funding: $150K / 2 years. Phase II funding for an additional $50K may be approved later, to support research costs during the 1st year of an independent research position.

http://www.amfar.org/Mathilde-Krim-Fellowships-in-Basic-Biomedical-Research-Deadline-May15-2014

 

15.5 | Friedreich's Ataxia Research Alliance (FARA) - Letter of Intent

Bronya J. Keats Award for International Collaboration

FARA accepts LOIs focusing on FA research that relies on international collaboration among investigators in at least 2 different countries. Special consideration will be given to proposals that bring new scientists to the FA community. Funding: $200K/year for 1-2 years.

Phillip Bennett and Kyle Bryant Translational Research Award

FARA accepts LOIs focusing on pre-clinical and clinical investigations that will advance treatments for FA. Funding: $250K/year for 1-2 years. Aims must target one or more of the following:

* Identification of biomarkers for FA that will elucidate disease variability, severity, and prognosis; facilitate drug screening, and/or optimize selection of patients and clinical endpoints for clinical trials;

* Development of tools and technologies that can (a) be directly used for therapy development; (b) overcome existing obstacles to treatment and (c) be directly applied to, or adapted for, delivery of potential therapeutics;

* Pre-clinical development and testing of potential therapeutics, biologics, and devices in cells and animals;

* Clinical studies of patient outcome measures, potential interventions, or devices.

http://www.curefa.org/types-of-grants.html#kma

 

19.5 | NIH / National Institute of Allergy and Infectious Diseases: Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens – LOI

Projects focused on development and/or production of diagnostics that will enable rapid, sensitive, specific, culture-independent detection of high-priority antimicrobial-resistant Gram-negative bacterial pathogens, including: Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species and extra-intestinal pathogenic Escherichia coli. Funding: up to $750K/year + $300K for equipment for up to 5 yrs.

http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-019.html

 

20.5 (20.6) | NIH / National Cancer Institute (NCI): "Provocative Questions" Initiative in Cancer Research - LOI

This initiative has assembled a list of 20 important questions to stimulate the research communities to use laboratory, clinical and population sciences in especially effective and imaginative ways to answer the questions. Funding: RO1 - 4 years, amount unlimited; R21 - $275K over 2 years.

Group A: Cancer Prevention and Risk

A1: How do decision making processes influence habitual behaviors, and how can that knowledge be used to design strategies that lead to adoption and maintenance of behaviors that reduce cancer risk?

A2: How does the level, type, or duration of physical activity influence cancer risk and prognosis?

A3: What biological mechanisms influence susceptibility to cancer risk factors at various stages of life?

A4: For tumors that arise from a pre-malignant field, what properties of cells in this field can be used to design strategies to inhibit the development of future tumors?

Group B: Mechanisms of Tumor Development or Recurrence

B1: Why do second, independent cancers occur at higher rates in patients who have survived a primary cancer than in a cancer-naïve population?

B2: What molecular and cellular events in the tumor microenvironment (for example, the local immune response) determine if a tumor at the earliest stages of malignant transformation is eliminated, stimulated for further development, or made indolent?

B3: What mechanisms initiate or sustain cancer cachexia, and can we target them to extend lifespan and quality of life for cancer patients?

B4: What methods can be devised to characterize the functional state of individual cells within a solid tumor?

Group C: Tumor Detection, Diagnosis, and Prognosis

C1: What properties of pre-cancerous lesions or their microenvironment predict the likelihood of progression to malignant disease?

C2: What molecular or cellular events establish tumor dormancy after treatment and what leads to recurrence?

C3: How do variations in tumor-associated immune responses among patients from distinct well-defined populations, such as various racial/ethnic or age groups, contribute to differences in cancer outcomes?

C4: What in vivo imaging methods can be developed to portray the "cytotype" of a tumor — defined as the identity, quantity, and location of each of the different cell types that make up a tumor and its microenvironment?

Group D: Cancer Therapy and Outcomes

D1: What molecular properties make some cancers curable with conventional chemotherapy?

D2: What features of standard-of-care therapies enhance or inhibit the efficacy of immunotherapy?

D3: Do tumors evolve common features that could act as new therapeutic targets when they metastasize to the same secondary site?

D4: What are the mechanistic bases for differences in cancer drug metabolism and toxicity at various stages of life?

Group E: Clinical Effectiveness

E1: What strategies optimize adoption and sustainability of guideline concordant cancer treatments in community settings?

E2: What care delivery models can be developed to transition cancer patients effectively from active therapy to end of life care?

E3: What methods and approaches induce physicians and health systems to abandon ineffective interventions or discourage adoption of unproven interventions?

E4: What are the best methods to identify and stratify subgroups of patients with particular co-morbidities who will benefit from defined cancer therapies?

Key Dates: Application deadline is 20.6. Letter of Intent due 20.5 (is not mandatory, not binding, and does not enter into the applications review, yet it allows IC staff to estimate the potential review workload and plan the review).

http://provocativequestions.nci.nih.gov/  |  http://provocativequestions.nci.nih.gov/rfa

 

21.5 | Society for Neuroscience: Outstanding Research and Career Awards

The awards, in amount of $25K each, are presented to scientists who have made outstanding contributions to the field through research and other scientific achievements. If one or more of the following statements apply, you may be eligible for an award:

You have made significant contributions to neuroscience throughout your career.

You have made noteworthy advances in theoretical and computational neuroscience or neuropharmacology.

You have conducted or plan to conduct research in the area of substance abuse and the brain or nervous system.

You have mentored other neuroscientists or neuroscience students.

Julius Axelrod Prize: for a scientist with distinguished achievements in neuropharmacology (or a related area) and exemplary efforts in mentoring young scientists.

Ralph W. Gerard Prize: for an outstanding scientist who has made significant contributions to neuroscience.

Swartz Prize for Theoretical and Computational Neuroscience: for individuals who, over a period of time, have made significant contributions or advances in theoretical and computational neuroscience.

Jacob P. Waletzky Award: for a scientist who has conducted research or plans to conduct research in the area of substance abuse and the brain and nervous system.

http://www.sfn.org/awards-and-funding/individual-prizes-and-fellowships/outstanding-research-and-career-awards

 

22.5 | DOD-CDMRP: Ovarian Cancer Research Program - competitive pre-application

- Pilot Award: Supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements. Innovation and Impact are important criteria. Optional nested Teal Postdoctoral Scholar: Applications having postdoctoral candidates that meet the criteria outlined in the Program Announcement will qualify for higher funding. Preliminary data are not required, but are allowed. Clinical trials are not allowed. Funding: $225K / 2 years ($300K with a nested Teal Postdoctoral Scholar).

https://ebrap.org/eBRAP/public/Program.htm

 

22.5 | Alzheimer’s Drug Discovery Foundation (ADDF): Translational and Clinical Research on Alzheimer’s Disease (Proposal due 5.6, LOI due 2 weeks prior)

ADDF funds 4 categories of research; drug discovery and preclinical development, early detection, clinical trials and prevention. ADDF does not fund basic research. ADDF is interested in novel targets and therapeutic approaches for Alzheimer’s Disease (AD), related dementias and cognitive aging. These areas include, but are not limited to: Energy utilization/mitochondria function, insulin sensitivity, protein degradation/autophagy, ApoE function and cholesterol metabolism, vesicular trafficking, inflammatory pathways, synaptic function/morphology, calcium regulation, myelin changes, ischemia and oxidative stress, vascular injury, the blood-brain barrier interface, and translatable biomarkers. ADDF has limited interest in funding anti-amyloid approaches and has limited interest in funding cholinesterase inhibitor programs. Funding priorities: Early identification; Prevention of AD and cognitive decline; Treatment of AD and cognitive aging.

* Repurposing Drugs for AD and Related Dementias Including: phase I-II human clinical trials, animal model studies and other preclinical development work required to bring a repurposed drug into human clinical testing for AD or related dementia. Funding: $100K - $1.5M.

* Preclinical Drug Discovery: ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising preclinical drug discovery and biomarker development programs relevant to AD, other dementias and cognitive aging. ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding averages $150K/year. In some cases, multi-year proposals can be considered.

* Program to Accelerate Clinical Trials: funding for up to $1.5M per application, is offered to increase the number of innovative drugs tested in humans for AD, related dementias and cognitive aging. This program will fund biomarker-based pilot clinical trials for AD and in some cases will also support Phase I safety testing and IND-enabling studies to accelerate new drugs into trials. ADDF is also interested in supporting targeted pharmacological and non pharmacological approaches to prevention and clinical biomarker development programs. Areas of particular interest include:

- Repurposing: testing drugs approved for other indications in AD clinical trials.

- Therapies addressing the following targets: energy utilization/mitochondria function, insulin sensitivity, protein degradation/autophagy, ApoE function and cholesterol metabolism, vesicular trafficking, inflammatory pathways, synaptic function/morphology, calcium regulation, myelin changes, ischemia and oxidative stress, vascular injury and the blood-brain barrier interface.

* ADDF/NIH: financial assistance for relevant NIA and NINDS grant applications that were scored but not funded AND fall within the ADDF’s current funding priorities (Application deadline is rolling)

http://www.alzdiscovery.org/research-and-grants/request-for-proposal

 

28.5 | Michael J. Fox Foundation for Parkinson’s Research - Pre-Proposals:

- Target Validation Program: Supports work seeking to determine if manipulating a novel biological target has impact in a PD-relevant animal model. MJFF does not have any pre-conceived preferences for particular targets, however there are recommended targets (see link). Funding: up to $250K over 2 years.

- Therapeutic Pipeline Program: The foundation seeks to stimulate development of Parkinson’s disease (PD) therapeutics with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care. No official budget limit, applicants may request up to 2 years for preclinical development or up to 3 years for clinical development. Although open to any creative therapeutic strategy, ideal applications should focus on one of the following treatment challenges:

* Protect or restore degenerating and/or dysfunctional neurons affected in PD.

* Alleviate disabling motor and non-motor symptoms of PD

* Alleviate complications of PD treatment including dyskinesias and other disabling side effects.

https://www.michaeljfox.org/research/apply-for-grant.html

 

30.5 | Paul G. Allen Family Foundation: Artificial Intelligence Research

Pioneering research in academic settings that is unlikely to receive funding from traditional governmental sources, focusing on 3 fundamental topics:  

- Machine Reading

- Diagram Interpretation

- Spatial and Temporal Reasoning

Funding: five to eight projects with total funding of $1 million to $2 million for each project, over 3 yrs.

http://www.pgafamilyfoundation.org/programs/investigators-fellows/key-initiative/adi-artificial-intelligence-rfp

 

30.5 | DOD-CDMRP: Funding Opportunities for FY14 - Program Pre-Announcements

The Fiscal Year 2014 Department of Defense Appropriations Act provides research funding for the following peer reviewed programs managed by the Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP):

•Autism Research Program - $6.0 million

•Breast Cancer Research Program - $120.0 million

Duchenne Muscular Dystrophy Research Program - $3.2 million

•Gulf War Illness Research Program - $20.0 million

•Neurofibromatosis Research Program - $15.0 million

•Peer Reviewed Cancer Research Program - $25.0 million

•Peer Reviewed Medical Research Program - $200.0 million

•Peer Reviewed Orthopaedic Research Program - $30.0 million

•Prostate Cancer Research Program - $80.0 million

•Spinal Cord Injury Research Program - $30.0 million

•Tuberous Sclerosis Complex Research Program - $6.0 million

Subsequent notifications will be sent when the program announcements are released.

Detailed Pre-Announcements for each program: http://cdmrp.army.mil/pubs/press/press.shtml

Active calls: https://ebrap.org/eBRAP/public/Program.htm

 

31.5 | CHEST Foundation 2014 Grants and Awards Program

- Clinical Research Grant in Lung Cancer - $100,000 over 2 years.

- Clinical Research Grant in Pulmonary Arterial Hypertension - $50,000 for 1 year.

- Clinical Research Grant in Pulmonary Fibrosis - $30,000 for 1 yr

- Clinical Research Grant in COPD and Alpha-1 Antitrypsin (AAT) Deficiency - $25,000 for 1 yr

http://www.chestnet.org/Foundation/What-We-Do/Apply-for-a-Grant#DS

 

31.5 | Baxter International: Baxter BioScience Grants

Currently interested in supporting research in the following areas:

- Immunology

- Neurology

- Hematology

- BioSurgery

- Pulmonology

 -Regenerative Medicine

Funding: up to $125K

https://www.baxterbiosciencegrants.com/biogrants/researchGrants.jspa

 

31.5 | MO BIO Laboratories: Microbiome Awards

The Awards provides young, extraordinary scientists with funding and recognition to carry out scientific work in the field of Microbiome research. Entrants must have been awarded their Ph.D in the last 5 years. The program will award 3 prizes in amount of $2K, $3K, $5K, and the winner of the competition will receive a Research Package consisting of the analysis of 100 microbiome samples by the EMP consortium. The sample analysis includes Nucleic acid extraction (using MO BIO products) and targeted amplicon analysis (16S rDNA).

http://www.microbiomeproject.com/

 

1.6 | Cystic Fibrosis Foundation Therapeutics Inc.: Clinical Research Award LOI

Projects may address diagnostic or therapeutic methods related to CF or its pathophysiology. Applicants must demonstrate access to a sufficient number of CF patients from CF Foundation-accredited care centers and to appropriate controls. Funding:  $100K/year for up to 3 years for single center clinical studies and $225K/year for multi-center clinical studies.  May also apply for spring 1.12 LOI deadline.

http://www.cff.org/research/ForResearchers/FundingOpportunities/ClinicalResearchAwards/

 

1.6 | A Foundation Building Strength (AFBS): Research on Nemaline Myopathy (NM)

The goal of this grant is to advance understanding of the pathogenesis of NM in order to design and optimize treatment and management strategies. For this round the primary objective are: [1] Improving Access to Human Samples; [2] Improving Pulmonary Function;  [3] Improving Understanding of NM. Funding: $30K - $200K over one or more years.

http://www.buildingstrength.org/

 

1.6 | Wenner-Gren Foundation: International Collaborative Anthropological Research Grants

Supports international research collaborations between 2 or more scholars, where the PIs bring different and complementary perspectives, knowledge, and/or skills to the project. PIs must hold a Ph.D. or equivalent in anthropology or a related discipline. Funding: up to $35K.

http://www.wennergren.org/programs/international-collaborative-research-grants

 

1.6 | NIH/Center for Drug Evaluation Research & FDA:

Characterization of Critical Quality Attributes for Semisolid Topical Drug Products: to characterize all measurable physical/chemical qualities of different dosage forms of semisolid topical drug products, identify appropriate methodologies for measuring each attribute, characterize formulation and manufacturing parameters, and utilize in vitro and/or in vivo measures of product performance to correlate variations in critical quality attributes with a failure mode for a drug product. Funding: estimated total of $250K to fund one award.

http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-14-010.html

Physiologically Based Absorption and Pharmacokinetic Modeling and Simulation for Non-gastrointestinally Absorbed Drug Products in Humans:  to develop physiologically based absorption and pharmacokinetic (PK) models for complex drug products, such as locally acting drug products and non-biological complex parenteral drugs. Specific objectives are detailed in "Section I Funding Opportunity Description" in link below. Funding: $200K/year, for up to 3 yrs.

http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-14-012.html

 

3.6 | DOD-CDMRP: Ovarian Cancer Research Program - competitive pre-application

- Clinical Translational Leverage Award: Supports the leveraging of existing human-based ovarian cancer resources in translational research to investigate high-impact research ideas or unmet needs in ovarian cancer; Supports early-phase, proof-of-principle clinical trials (Phase 0 or I) or correlative studies (retrospective and prospective); Preliminary data are required; Clinical trials require cost sharing/matching. Funding: $250K / 2 years.

- Investigator-Initiated Research Award: Supports studies that significantly impact ovarian cancer research and/or patient care; Projects may focus on any research phase from basic through translational; Preliminary data relevant to ovarian cancer are required; Clinical trials are not allowed. Funding: $400K / 3 years.

- Ovarian Cancer Academy Dean and Assistant Dean (Leadership) Award: Academy Dean and Assistant Dean must be established ovarian cancer researchers. The program supports 2 visionary individuals who will synergistically facilitate the professional development of 10-12 Early Career Investigators, with assistance from their Designated Mentors, in the OCRP’s Ovarian Cancer Academy, a non-traditional, non-conventional training platform;  Academy Dean and Assistant Dean will be recognized as Partnering Principal Investigators and receive separate awards. Funding: $1.2M / 5 years.

- Ovarian Cancer Academy Award – Early-Career Investigator: Must be within the first 3 years of their first faculty position. Supports the addition of new Early-Career Investigators to the interactive virtual academy that will provide intensive mentoring, national networking and a peer group for junior faculty. Designated Mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required; Preliminary data are required; Clinical trials are not allowed; Institutional match of $50K/year is required. Funding: $725K / 5 years.

https://ebrap.org/eBRAP/public/Program.htm

 

3.6 | DOD-CDMRP: Lung Cancer Research Program - competitive pre-application

- Career Development Award: Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher. Clinical trials not allowed. Preliminary data not required. Military relevance strongly encouraged. Eligibility: Independent investigators at the level of Assist. Professor; must be within 5 years of first faculty appointment; Have not received a Career Development Award previously from CDMRP; Have not received more than $300K for other lung cancer research as PI. Mentor - At or above the level of Assoc. Professor; Have proven publication and funding record in lung cancer research. Funding: $400K / 3 years.

- Clinical Exploration Award

Clinical Trials: Supports rapid execution of hypothesis-driven, early-phase clinical trials to examine interventions that could have a major impact on lung cancer clinical management. Proposed studies will explore innovative and untested concepts to provide scientific rationale or initial proof-of-principle for larger clinical trials in lung cancer. Funding: $450K / 3 years.

Correlative Studies: Supports innovative, hypothesis-based correlative studies that derive from ongoing or completed clinical trials that have the potential to significantly inform treatment strategies, identify subset of patients for treatment with specific therapies, provide increased understanding of biological changes resulting from the intervention in lung cancer, or provide other insights that will significantly enhance clinical management of lung cancer.  Funding: $250K / 2 years.

The application must include documentation of an existing Investigational New Drug (IND) or Investigational Device Exemption (IDE), if applicable. The study is expected to begin no later than 12 months after the award date. Military relevance strongly encouraged.

- Idea Development Award: Supports new ideas that are in the early stages of development representing innovative, highrisk/high-gain research. Emphasis is on innovation and impact. Clinical trials not allowed. Preliminary data required, but may be from outside of lung cancer. Military relevance strongly encouraged

https://ebrap.org/eBRAP/public/Program.htm

 

3.6 | DOD-CDMRP: Multiple Sclerosis Research Program - competitive pre-application

- Investigator-Initiated Partnership Award: Supports partnerships between clinicians and research scientists that accelerate the movement of promising ideas in MS into clinical applications. Preliminary data required, but may be from outside of MS field; Clinical trials are not allowed. Funding: $1.2M / 3 years.

https://ebrap.org/eBRAP/public/Program.htm

 

3.6 | Leukemia & Lymphoma Society (LLS):  Quest For Cures (QFC) LOI

To identify and develop safer, more effective treatment paradigms for patients with hematological malignancies. This initiative will identify and fund priority research areas, with support from biotech and pharmaceutical partners in order to address significant unmet medical needs. The near-term goal is to advance the scientific and medical understanding of the various hematological malignances. Funding:  $200K - $400K annually, for 2 years. Eligible topics:

- Defining treatment algorithms that rely on predictive/prognostic biomarkers and molecular MRD surrogates to select standard or experimental therapies for patients with indolent lymphoid malignancies, particularly follicular NHL or early phase CLL, as well as patients with pre-malignant conditions such as MGUS, low risk MDS or MPNs (PV or ET);

- Characterizing hematopoietic events in the elderly that may predispose them to chronic pre-leukemic myeloid disorders and/or to progression from these states to frank hematologic malignancy.

Because of special requirements related to this grant, please contact Robi (x. 2152  robertg@technion) if you are considering applying.

http://www.lls.org/researchershealthcareprofessionals/academicgrants/quest_for_cures/

 

4.6 | American Chemical Society (ACS) Green Chemistry Institute (GCI): Pharmaceutical Roundtable Research Grant for Reduction of Amides

The Medicinal Chemistry group is seeking to fund a one year R&D program targeting the identification and development of alternatives to the commonly employed stoichiometric hydride-based reagents or transition-metal catalyzed silane reductions, with a focus on substrates that are widely applicable to the pharmaceutical industry. This collaborative project is intended for a student within the selected Principal Investigator's research group.  Funding: $50K for 1 yr.

https://www.acs.org/content/acs/en/funding-and-awards/grants/gci.html

 

6.6 | American Gastroenterological Association - Pfizer: JAK-IBD Research Grant on “the role of Janus kinase (JAK) pathways in IBD”

This award provides up to $200K over 2 years, to an investigator interested in studying the role of Janus kinase (JAK) pathways in the pathophysiology and immunology of inflammatory bowel disease (IBD).

http://www.gastro.org/aga-foundation/grants/agapfizer-jakibd-research-grant

 

10.6 | DOD-CDMRP: Peer Reviewed Cancer Research Program - LOI

Career Development Award – Supports independent, early career investigators to conduct impactful research with the mentorship of an experienced cancer researcher in at least one of the topic areas below. Funding: $360K over 3 years.

Idea Award with Special Focus - Supports innovative, untested, high-risk/potentially high reward concepts, theories, paradigms, and/or methods in cancer research with a “Special Focus” on the cancers associated with exposures, conditions, or circumstances that are unique to the military or disproportionately represented within the military beneficiary population. Must address at least one of the topic areas below, and at least one of the military relevance focus areas: Assessment of militarily-relevant risk factors (e.g., ionizing radiation, chemical, and environmental carcinogens) associated with the susceptibility, early detection, progression, and treatment of cancer, Examination of cancer diagnosis and prognosis effects on the psychosocial well-being of military and their beneficiaries, Gaps in cancer prevention, diagnosis, early detection, or treatment that may affect the general population but have a particularly profound impact on military health. Funding: $300K over 2 years.

Topic areas: Blood cancers, Cancers related to radiation exposure (New for FY1) ,Colorectal cancer, Genetic cancer research, Kidney cancer, Listeria vaccine for cancer, Melanoma and other skin cancer, Mesothelioma, Myeloproliferative disorders (New for FY14(, Neuroblastoma, Pancreatic cancer, Pediatric brain tumors, NOT: breast, prostate, lung (excluding mesothelioma), or ovarian cancer.

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=8900

 

15.6 | Eppendorf & Science: The International Prize for Neurobiology

Awarded annually to one young scientist for the most outstanding neurobiological research conducted by him/her during the past 3 years. Prize value: $25K.

http://www.sciencemag.org/site/feature/data/prizes/eppendorf/

 

16.6 | Lung Cancer Research Foundation: Research Grants

Provides seed support for cutting-edge scientific research on all cancers of the lung. Funding intended to build proof of concept for researchers to apply for additional grant funding from universities and public sources. Funding: $50K for one year.

http://www.lungcancerresearchfoundation.org/our-research/current-grants/

 

20.6 | Juvenile Diabetes Research Foundation (JDRF):

Combination Therapies in Type 1 Diabetes- LOI

JDRF solicits expressions of interest for clinical trials in new onset and established T1D to test the safety, efficacy, and potential synergies of combination therapies that target multiple facets of the disease. Proposed studies should: 1) Utilize two or more therapeutic agents targeting mechanisms involved in immune modulation, beta cell function and regeneration/replication, or metabolic control; 2) Have a clear plan for a regulatory path to allow the trial to be done; 3) Be based on a robust scientific hypothesis and preliminary data; and 4) Use pre-existing infrastructures for rapid recruitment of T1D patients, or at-risk individuals, into the proposed trial(s). Collaborative efforts engaging investigators with complementary expertise and/or combining multiple agents and patient cohorts are highly encouraged. This call is not intended to support pre-clinical efforts aimed at broadly exploring potential combinations for treating or preventing T1D. Focused, IND-enabling pre-clinical studies proposed in direct support of future clinical studies using combination approaches may be considered as part of this RFA – investigators proposing pre-clinical studies should contact JDRF. Funding: $1.5 million/yr for up to 3 yrs.

Diabetic Retinopathy Biomarker Discovery and Validation - LOI

Objective: to identify and validate novel functional, genetic or biochemical biomarkers of diabetic retinopathy with potential to 1) predict progression of NPDR, or 2) predict long-term treatment response. Studies may include: Ancillary studies of ongoing interventional or observational clinical trials related to progression of diabetic retinopathy, Analysis of data from current or past clinical trials to identify factors which predicted progression of NPDR or response to therapy, 3) New clinical studies to address these questions. Preclinical studies using animal or cellular models of diabetic retinopathy are not suitable for submission to this call. Funding: requests should be consistent with proposed activities. Duration: 3 yrs.

Exploratory Clinical Trials for Diabetic Retinopathy - LOI

Objective: innovative approaches to arrest or reverse NPDR or to resolve PDR. Exploratory and initial proof of concept clinical trials to provide rationale for larger or pivotal studies will be given highest priority. Clinical trials must include subjects with T1D; however trials will be considered which also propose enrollment of those with T2D. Proof of concept clinical studies may propose use of approved or investigational products based on an excellent scientific rationale. JDRF is particularly interested in clinical trials which propose novel means of subject stratification based on estimated risk of progression of NPDR. Funding: Not specified.

http://jdrf.org/grant-center/grant-opportunities-and-deadlines/

 

20.6 | Liam's Land: Hobbs Medical Research Grant in Lymphangioma

Grants to research to find the cause, treatment, or cure for lymphatic malformation (also known as cystic hygroma or lymphangioma). Funding: $25K/yr.

http://www.liamsland.org/liams-land-medical-reseach-grants/

 

27.6 | American Epilepsy Society: Seed Grant Program

Intended to foster collaborative interactions between two or more established investigators to make future grants related to epilepsy more competitive for larger awards. Designed to enable information exchange/technology transfer, travel of postdoctoral fellows between laboratories, and modest supplies for the project. Funding: $20K for 1 yr.

https://www.aesnet.org/research/fundng_resources/aes_research/seed_grant_program

 

1.7 | Union for International Cancer Control (UICC): Yamagiwa-Yoshida Memorial International Cancer Study Grants

3 months fellowship in value of $10K, to initiate, set-up or pursue bilateral cancer research projects with collaborating investigators abroad, to exchange and exploit complementary skills and material, as well as receive training in advanced experimental research methods. Funds basic, translational or applied cancer research. Prevention-oriented projects are especially encouraged. Eligibility: Possess PhD at least 2 years prior to the application closing date.

http://www.uicc.org/programmes/global-education-and-training-initiative-geti/fellowships

 

1.7 | NATO: Science for Peace and Security Programme (SPS)

The program supports collaborative projects in the areas of Defense Against Terrorism or Countering Other Threats to Security, with scientists from NATO countries*. Funding: up to €400K over 3 years. The program key Priorities:

1) Security challenges: (a) Counter-Terrorism (b) Energy Security (c) Cyber Defence (d) Defence against CBRN Agents (e) Environmental Security

2) Enhance support for NATO-led operations and missions: (a) Provision of civilian support through SPS Key Priorities (b) Provision of access to information through internet connectivity as in the SILK-Afghanistan Programme (c) Cultural and social aspects in military operations and missions (d) Enhancing cooperation with other international actors.

3) Enhance awareness on security developments: (a) Security-related Advanced Technology (b) Border and Port Security (c) Mine and Unexploded Ordnance Detection and Clearance (d) Human and Social Aspects of Security related to NATO’s strategic objectives.

Any project related clearly linked to a threat to security not otherwise defined in these priorities may also be considered.

* NATO countries: Albania, Belgium, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Turkey, UK and US.

Full list of topics:  http://www.nato.int/cps/en/natolive/85291.htm

http://www.nato.int/cps/en/natolive/87260.htm

 

2.7 | National MS Society (NMSS): Pilot Research

Support for short-term research in areas where preliminary data are scant or nonexistent. Designated to support unique or novel ideas with the potential to open significant new areas of research on MS. Funding: $40K for one year.

http://www.nationalmssociety.org/For-Professionals/Researchers/Society-Funding/Pilot-Research-Grants

 

11.7 | Juvenile Diabetes Research Foundation (JDRF): Clinical Trials to Preserve Beta Cell Function and Delay Onset of Symptomatic Disease in the At-risk Setting for T1D - LOI

Expressions of interest are sought from investigators with access to patient cohorts of individuals with ≥2 T1D autoantibodies to conduct proof-of-concept clinical trials using intermediate trial outcomes/endpoints to inform larger and longer prevention trials. Repurposed and/or novel therapeutics (immune, inflammation, beta cell survival, metabolic, etc.) will be considered. Combination therapies, used either sequentially or simultaneously, for robust prevention will also be considered. Proposals with a focus on primary prevention will not be considered. Funding: $1.5 million/yr for up to 3 yrs.

http://jdrf.org/grant-center/grant-opportunities-and-deadlines/

 

14.7 | Juvenile Diabetes Research Foundation (JDRF): Diabetic Nephropathy Biomarker Discovery and Validation Using Type 1 Diabetes Cohorts - LOI

Objective: addressing the lack of validated biomarkers to predict progression to more severe disease and/or to predict treatment response in clinical trials, by utilizing well characterized T1D cohorts to discover and validate such biomarkers. The aim of this request is to catalyze collaborative research between talented research groups with critical clinical and data resources as well as those with appropriate analytic methods in order to accelerate progress in DN biomarker validation towards clinical utility. It is not expected that new interventional trials be proposed in response to this call. Funding: $1.5 million/yr for up to 3 yrs.

http://jdrf.org/grant-center/grant-opportunities-and-deadlines/

 

15.7 | CurePSP: Research Grants in Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD)

CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular and cellular levels. Funding: Up to $100K over 3 years.  Particular interests:

Understand the role of the tau gene and other genes.

1. Understand the role of the tau gene and other genes.

2. Understand the role of tau protein processing.

3. Understand cellular energy metabolism and oxidative stress perturbations.

4. Understand environmental factors that influence the development or course of these disorders.

5. Understand the series of changes in brain cells pass as they progress from healthy neurons to dysfunctional neurons.

6. Characterize the natural history in order to develop outcome measures for clinical trials.

7. Develop animal models.

8. Develop tools for early diagnosis.

9. Develop treatments that improve the symptoms.

10. Develop interventions to arrest the progression and/or restore lost function.

http://www.psp.org/research/researchers/

 

15.7 | AO Foundation: AO Start-up grants: 'The healing of musculoskeletal tissues'

Proposals should focus on AO general area of interest, 'The healing of musculoskeletal tissues', and its investigation of the understanding of normal or disturbed  healing, implant technology (including bone/implant interface, scaffolds) and IT solutions to enhance clinical techniques. Eligible: Young investigators within 5 years of the completion of their terminal degree or within 5 years of initiation of their first assist. professor position.  Experienced researchers submitting novel high-risk projects. Funding: CHF60K (~$66K) for one year projects or CHF90K (~$100K) for 1.5 year projects.

https://www.aofoundation.org/Structure/research/research-funding/Pages/Start-up-grants.aspx

 

15.7 | National Ataxia Foundation: Research Grant - Letter of intent

One-year seed grants of $15K-$30K will be considered for early or pilot phases of studies and ongoing investigations.

http://www.ataxia.org/research/ataxia-research-grants.aspx

 

15.7 | EFSD and Novartis: European Research Programme in Microvascular Complications of Diabetes

Acceleration of European basic and clinical research focusing on microvascular complications of diabetes. Hypothesis driven basic and clinical intervention projects (projects not involving clinical trials).  Funding: up to €100K.

http://www.europeandiabetesfoundation.org/index.php/ct-menu-item-5/9-general-pages/216-efsd-novartis

 

25.7 | Alpha-1 Foundation: Gordon L. Snider Scholar Award

Objective: to provide additional career development support for outstanding young investigators who have continued to conduct research in Alpha-1-related lung or liver disease after completion of their postdoctoral fellowship. It is expected that the award will provide an incentive for a career in Alpha-1 research. Funding: $75K /yr over 3 years.

http://alpha-1foundation.org/research-grant-opportunities/

 

30.7 | U.S Department of Health and Human Services- BARDA: Advanced Development of Medical Countermeasures for Pandemic Influenza

To promote innovations in technologies that may assist to advance medical countermeasures research and development, research and development of tools, devices, and technologies, and research to promote strategic initiatives, such as rapid diagnostics, broad spectrum antimicrobials, and vaccine manufacturing technologies. This program will support advanced development activities to mature candidate products and to better address considerations of the challenging lifecycle requirements of these products before and during a pandemic (e.g. shelf life, storage, distribution, and dispensing). Additional focus will be placed on medical countermeasures and devices suitable for use in at-risk populations. Multiple awards of various values will be granted, total funds allocated for the program are up to $300M.  Areas of Interest:

1. Personal Protective Equipment (Masks and Respirators) for Influenza Infection & All-Hazards

2. Full-Featured Continuous Ventilators for Influenza Infection and All-Hazards

3. Clinical Influenza Test Systems and Diagnostic Tools

4. Influenza Therapeutics

5. Influenza Vaccines

6. Influenza Vaccine Manufacturing Improvement

https://www.fbo.gov/index?s=opportunity&mode=form&id=2a07976de196772ee806e82d899bf38c&tab=core&_cview=1

 

31.7 | Ernst Abbe Fund: Otto Schott Research Award in glass and glass-ceramic sciences

The Award (in amount of € 25K) recognizes excellent researchers for their scientific and technological achievements in basic research and applications in the fields of glass and glass-ceramic sciences in the areas of optics and electronics, solar power, health, and lifestyle.

http://www.otto-schott-research-award.de/

 

31.7 | Cutaneous Lymphoma Foundation (CLF): 2014 CLARIONS Award Program in Cutaneous Lymphomas

The program funds innovative research in all areas of Cutaneous Lymphomas with particular interest in:

• Etiology and risk factors of cutaneous lymphomas.

• Measures of disease impact on individuals and populations affected by cutaneous lymphomas.

• Translating discoveries into diagnostic and therapeutic advances in cutaneous lymphomas.

• Optimizing therapies for cutaneous lymphomas.

• Improving quality of life for individuals with cutaneous lymphomas

Funding: $25K for 1 yr.

http://www.clfoundation.org/research/research-awards-program

 

1.8 | Kenneth Rainin Foundation: Synergy Award in Inflammatory Bowel Disease (IBD)

To encourage collaboration among health researchers from across disciplines to advance the study of IBD. The award will fund groundbreaking or unconventional methodologies, whose risky outlook is justified by the possibility of a major breakthrough. The Award provides $100K for one year to each investigator on the team, up to $300K. Additional funding will be available on a competitive basis after the initial grant term. To be considered for the Award, one or more of the researchers from the team must register and attend the Foundation’s 2014 Innovations Symposium, Taming the Microbiome - July 15-16, 2014.            

http://rainin-symposium.com/event/synergy-award

http://rainin-symposium.com

 

1.8 | DOD-CDMRP: Breast Cancer Research Program - Letter of Intent

- Era of Hope Scholar Award: Supports exceptionally talented, creative early-career scientists, within 6 years of their last training position, who are the “best and brightest” in their fields. PIs should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention. PIs should exhibit strong potential for leadership in the breast cancer community. Breast cancer advocates must be included in the research team. Funding: $2.5M / 5 years.

https://ebrap.org/eBRAP/public/Program.htm

 

1.8 | National Ataxia Foundation: Young Investigator Awards - Letter of Intent

 - Young Investigator (YI) Award: one-year grant of $35K to encourage young investigators to pursue a career in the field of any form of ataxia research.

 - Young Investigator (YI-SCA) Award for SCA Research: 3 one-year grants of $50K will be awarded to encourage young investigators to pursue a career in pinocerebellar ataxia (SCA) research.

For both programs, candidates must have attained an MD or PhD degree, and have an appointment as a junior faculty member, senior post-doc or clinical fellow. Individuals at the Associate Professor level are not eligible. Clinicians must have finished their residency no more than 5 years prior to applying. PhDs must be no more than 5 years from end of the completion of their post-doc training.

http://www.ataxia.org/research/ataxia-research-grants.aspx

 

1.8 | Russell Sage Foundation: Project Awards in Basic Social Science - letter of inquiry

The Foundation supports basic social science research within the "announced programs" (see below). The major awards range between $35K - $200K.

- Behavioral Economics –insights of psychology into the study of economic behavior, with a particular focus on improving consumer financial decision making.

- Cultural Contact – the effects of cultural difference on the ways in which different groups in the population understand and interact with one another, with particular attention to the response of U.S. economic, social, political, and other institutions to increasing diversity in the U.S. population.

- Future of Work – examining the causes and consequences of the declining quality of jobs for less- and moderately-educated workers in the U.S. economy and the role of changes in employer practices, the nature of the labor market and public policies on the employment, earnings, and the quality of jobs of American workers.

- Immigration – examines social, economic, political, and community changes in the context of contemporary immigration and the role of race, nativity and legal status on the prospects for integration of immigrants and their children.

- Social Inequality – research on whether rising economic inequality has affected social, political, and economic institutions in the U.S., and the extent to which increased inequality has affected equality of opportunity, social mobility, and the intergenerational transmission of advantage.

http://www.russellsage.org/how-to-apply

http://www.russellsage.org/rsf-research-programs

 

1.8 | Guggenheim Foundation: Violence Research

Proposals from any of the natural and social sciences and the humanities that increase understanding of the causes, manifestations, and control of violence, aggression, and dominance. HFG ordinarily makes awards in the range of $15K-$40K/year for 1-2 years.

http://www.hfg.org/rg/guidelines.htm

 

6.8 | National MS Society (NMSS): Research Grants

Studies related to MS that may serve in preventing, treating and curing MS and improving quality of life. NMSS supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation. Before submitting a proposal, investigators must consult the Research & Clinical Programs Department by phone or email to determine whether the research plan is appropriate and relevant to our goals. NMSS supports studies for terms of 1-5 years

http://www.nationalmssociety.org/ms-clinical-care-network/researchers/get-funding/research-grants/index.aspx

 

15.8 | Hirshberg Foundation For Pancreatic Cancer Research: Seed Grant in Pancreatic Cancer

The grant is intended: To provide start-up funding for basic scientists and clinicians who intend to test innovative ideas for improving diagnosis and to develop new treatment modalities for pancreatic cancer;  To obtain preliminary data required for additional funding from other agencies;  To impact on the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy;  To establish collaborations within the field for mutual projects that can be considered for further funding. The first PI has to be affiliated to a US institution but funds may be requested also for non-US partner.  Funding: $50K for one year with possible extension for one more year upon a competitive renewal/ progress report.

http://www.pancreatic.org/site/c.htJYJ8MPIwE/b.891985/k.3234/Seed_Grants.htm

 

15.8 | National Ataxia Foundation: Letter of Intent

Pioneer SCA Translational Research Award: research investigations that will facilitate the development of treatments for the Spinocerebellar Ataxias (SCAs).  Funding: $100K for one year.

Research Post-Doc Fellowship Award: One-year grant up to $35K. Applicants should have completed at least one year of post-doctoral training, but not more than 2 at the time of application, and should have shown a commitment to research in the field of ataxia.

http://www.ataxia.org/research/ataxia-research-grants.aspx

 

22.8 | Alzheimer’s Drug Discovery Foundation (ADDF): Translational and Clinical Research on Alzheimer’s Disease (Proposal due 5.9, LOI due 2 weeks prior)

ADDF funds 4 categories of research; drug discovery and preclinical development, early detection, clinical trials and prevention. ADDF does not fund basic research. ADDF is interested in novel targets and therapeutic approaches for Alzheimer’s Disease (AD), related dementias and cognitive aging. These areas include, but are not limited to: Energy utilization/mitochondria function, insulin sensitivity, protein degradation/autophagy, ApoE function and cholesterol metabolism, vesicular trafficking, inflammatory pathways, synaptic function/morphology, calcium regulation, myelin changes, ischemia and oxidative stress, vascular injury, the blood-brain barrier interface, and translatable biomarkers. ADDF has limited interest in funding anti-amyloid approaches and has limited interest in funding cholinesterase inhibitor programs. Funding priorities: Early identification; Prevention of AD and cognitive decline; Treatment of AD and cognitive aging.

* Preclinical Drug Discovery: ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising preclinical drug discovery and biomarker development programs relevant to AD, other dementias and cognitive aging. ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding averages $150K/year. In some cases, multi-year proposals can be considered.

* Program to Accelerate Clinical Trials: funding for up to $1.5M per application, is offered to increase the number of innovative drugs tested in humans for AD, related dementias and cognitive aging. This program will fund biomarker-based pilot clinical trials for AD and in some cases will also support Phase I safety testing and IND-enabling studies to accelerate new drugs into trials. ADDF is also interested in supporting targeted pharmacological and non pharmacological approaches to prevention and clinical biomarker development programs. Areas of particular interest include:

- Repurposing: testing drugs approved for other indications in AD clinical trials.

- Therapies addressing the following targets: energy utilization/mitochondria function, insulin sensitivity, protein degradation/autophagy, ApoE function and cholesterol metabolism, vesicular trafficking, inflammatory pathways, synaptic function/morphology, calcium regulation, myelin changes, ischemia and oxidative stress, vascular injury and the blood-brain barrier interface.

* ADDF/NIH: financial assistance for relevant NIA and NINDS grant applications that were scored but not funded and fall within the ADDF’s current funding priorities (Application deadline is rolling)

http://www.alzdiscovery.org/research-and-grants/request-for-proposal

 

31.8 | International Team for Implantology: Research Programs

Funding for Implantology preclinical and clinical research in implant dentistry and related fields. Two types of grants:

Small Grant: for young clinicians who have been working within established groups and wish to expand their scope and level of responsibility. It is also intended for newer investigators who want to establish a track record in implant dentistry. This may be by pursuing their own research interests or by building up their own research group. Funding: up to $49,500.
Clinical or Laboratory Research Grant: for experienced researchers or research groups that have established a reputation for credibility and thoroughness in the field. Funding: up to $198,000.

http://www.iti.org/?a=1&t=0&y=3001&r=0&n=265&i=&c=25&v=page&o=&s

 

31.8 | FSH Society: the molecular genetics and cause of Facioscapulohumeral Muscular Dystrophy - Letter of Intent

Regular Grants: research relevant to understanding the molecular genetics and cause of Facioscapulohumeral Muscular Dystrophy (FSHD). Areas of interest include tissue, cell and molecular biology studies of FSHD and the development of animal models for FSHD. Research should involve isolation and characterization of the causative gene(s) and understanding of the genetic, neuromuscular and developmental mechanisms of the disease. Further, there is interest in the development of gene therapy and other therapeutic programs that may arise from that understanding. Funding: up to $45K/year for up to 2 years.

Senior Researcher Fellowship: research projects that contribute to identifying and understanding the basic defect of FSHD. Funding: up to $50K for one year with possible renewal for up to 3 years.

http://www.fshsociety.org/pages/resGOverview.html

 

31.8 | Bayer HealthCare Pharmaceuticals: Bayer HealthCare Grants4Targets Initiative

Bayer HealthCare allocates grants for the exploration of attractive, novel drug targets in the fields of:

*Oncology: focus on anti-proliferative, survival signaling, transcription and chromatin modulation, cell cycle regulation, tumor metabolism, hypoxia, immunotherapy and antibody-drug conjugates;

*Gynecology: focus on novel treatment options for endometriosis (incl. adenomyosis uteri/endometriosis interna) and uterine fibroids (uterine leiomyoma);

*Cardiology: focus on novel approaches to the care of chronic and/or acute pulmonary hypertension, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occlusive disease, acute lung injury/adult respiratory distress syndrome, cardiorenal syndrome and chronic kidney diseases;

*Hematology: focus on hemophilia, anemia and thrombocytopenia.

Support Grants (€5,000-€10,000) to further advance research on targets that are at a very early stage of discovery; IP rights remain with the applicant.

Focus Grants (€10,000-€125,000) for more mature ideas, e.g. to address specific aspects of a target as a first step towards transferring it to the drug discovery process; IP rights remain with the applicant.

In addition to the financial grants, Bayer may support further work by providing expertise, tools and/or investigations in the areas of: antibodies, small molecule tool compounds, biobank samples, and technologies.

http://www.grants4targets.com/scripts/pages/en/index.php

 

31.8 | Baxter International: Baxter BioScience Grants

Currently interested in supporting research in the following areas:

- Immunology

- Neurology

- Hematology

- BioSurgery

- Pulmonology

 -Regenerative Medicine

Funding: up to $125K

https://www.baxterbiosciencegrants.com/biogrants/researchGrants.jspa

 

1.9 | Wings for Life Spinal Cord Research Foundation (WFL): Projects in Spinal Cord Research - Executive Summaries

WFL promotes basic and clinical research related to spinal cord injury. Projects may address all aspects of spinal cord lesions, nerve regeneration, trophic support of lesioned neurons, and functional changes induced by lesions - preferentially in mammals. Proposals should have a view to translation from the laboratory to the clinical setting and have the potential to provide real benefits to human patients. Clinical research projects can be situated in the fields of diagnosis, acute lesion management including surgery, neurology, urology, rehabilitation, and other areas related to paraplegia.

A- Individual Grants: this grant is intended only to cover the salary of the applicant: for established investigators, post-docs, PhDs and technicians (up to 42K/year).

B- Project Research Grants: intended to sustain a full research project. (70K year).

C- Translational studies: translational studies of promising concepts aiming to foster the translational process. A relevant clinical endpoint is envisaged.

D- Early stage clinical trials: early stage clinical trials (including diagnostic and interventional trials).

Scientists intending to apply for funding schemes of section C or D are requested to contact Wings for Life beforehand for detailed funding options, given a flexible funding format.

http://www.wingsforlife.com/en/latest/grant-application-479/

 

1.9 | European Synchrotron Radiation Facility (ESRF): Application for Beam Time ***

ESRF beamlines are designed for research in diverse areas as: engineering, physics, chemistry, crystallography, earth science, biology and medicine, surface and materials science, and are characterized by specific techniques of investigation. Beamlines of similar techniques or activities have been grouped together to form 10 Review Committees.

http://www.esrf.eu/UsersAndScience/UserGuide/Applying

Long-Term projects provide beamtime during up to six successive scheduling periods (three years). Application deadline for Long-Term Proposal is 15.1.2014.

http://www.esrf.eu/UsersAndScience/UserGuide/Applying/LongTermProjects

 

10.9 | Parkinson's UK: Innovation Grants

Looking for high-risk, high-reward research that could lead to exciting breakthroughs in the causes, treatment and cure of Parkinson's, tackling major scientific or technical hurdles in the field. Funding: £35K for one year.

http://www.parkinsons.org.uk/content/innovation-grants

 

15.9 | Scleroderma Foundation:  Established Investigator Award

This award seeks applications from promising established investigators both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.  Funding: up to $150K for up to 3 years.

http://www.scleroderma.org/site/PageServer?pagename=prof_research_types

 

26.9 | American Epilepsy Society: Seed Grant Program

Intended to foster collaborative interactions between two or more established investigators to make future grants related to epilepsy more competitive for larger awards. Designed to enable information exchange/technology transfer, travel of postdoctoral fellows between laboratories, and modest supplies for the project. Funding: $20K for 1 yr.

https://www.aesnet.org/research/fundng_resources/aes_research/seed_grant_program

 

1.10 | NATO: Science for Peace and Security Programme (SPS)

The program supports collaborative projects in the areas of Defense Against Terrorism or Countering Other Threats to Security, with scientists from NATO countries*. Funding: up to €400K over 3 years. The program key Priorities:

1) Security challenges: (a) Counter-Terrorism (b) Energy Security (c) Cyber Defence (d) Defence against CBRN Agents (e) Environmental Security

2) Enhance support for NATO-led operations and missions: (a) Provision of civilian support through SPS Key Priorities (b) Provision of access to information through internet connectivity as in the SILK-Afghanistan Programme (c) Cultural and social aspects in military operations and missions (d) Enhancing cooperation with other international actors.

3) Enhance awareness on security developments: (a) Security-related Advanced Technology (b) Border and Port Security (c) Mine and Unexploded Ordnance Detection and Clearance (d) Human and Social Aspects of Security related to NATO’s strategic objectives.

Any project related clearly linked to a threat to security not otherwise defined in these priorities may also be considered.

* NATO countries: Albania, Belgium, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Turkey, UK and US.

Full list of topics:  http://www.nato.int/cps/en/natolive/85291.htm

http://www.nato.int/cps/en/natolive/87260.htm

 

1.10 | John Templeton Foundation: Core Funding Areas (Online Funding Inquiry Form)

** Science & the Big Questions:

- Mathematical & Physical Sciences: Foundational questions in mathematics or that seek a deeper understanding of the nature of reality within the realm of physics, cosmology, astronomy, chemistry, or other physical sciences. Projects that are unlikely to be supported by conventional funding sources are especially encouraged.

- Life Sciences: Projects investigating the evolution and fundamental nature of life, human life, and mind, especially as they relate to issues of meaning and purpose. Projects are welcome from a variety of disciplinary perspectives, including the biological sciences, neuroscience, archeology, and paleontology.

- Human Sciences: Projects that apply the tools of anthropology, sociology, political science, and psychology to the various moral and spiritual concepts as altruism, creativity, free will, generosity, gratitude, intellect, love, prayer, and purpose.

- Philosophy & Theology: Projects that attempt to develop new philosophical and theological insights, especially (but not only) in relation to advances in scientific understanding.

- Science in Dialogue: Projects that bring one or more scientific disciplines into a mutually enriching discussion with theology and/or philosophy, whether for a scholarly audience or the public at large.

** Character Development

** Freedom & Free Enterprise

** Exceptional Cognitive Talent & Genius:

Funding term: typically ranges from a few months to up to three years with amounts ranging from $200K to more than $1M.

www.templeton.org/what-we-fund/core-funding-areas

 

1.10 | National MS Society (NMSS): Pilot Research

Support for short-term research in areas where preliminary data are scant or nonexistent. Designated to support unique or novel ideas with the potential to open significant new areas of research on multiple sclerosis. Funding: $40K for 1 year.

http://www.nationalmssociety.org/For-Professionals/Researchers/Society-Funding/Pilot-Research-Grants

 

15.10 | International Team for Implantology: André Schroeder Research Prize

For new findings in implant dentistry, oral tissue regeneration and related fields. Funding: CHF 20K (~$22K)

http://www.iti.org/?a=1&t=0&y=3001&r=0&n=160&i=&c=25&v=page&o=&s=

 

15.10 | ALS Therapy Alliance (ATA) Grant Funding

ATA is accepting applications from investigators for ALS research projects. Grants ranging from $100,000 to $1 million over 1-3 years will be awarded to projects — including but not limited to basic, clinical, and translational research and clinical trials — related to a better understanding of or treatments for ALS.

http://alstherapyalliance.org/index.php/research/grant-submission-process.html

 

15.10 | CurePSP: Research Grants in Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD)

CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular and cellular levels. Funding: Up to $100,000 over 3 years.  Particular interests:

Understand the role of the tau gene and other genes.

1. Understand the role of the tau gene and other genes.

2. Understand the role of tau protein processing.

3. Understand cellular energy metabolism and oxidative stress perturbations.

4. Understand environmental factors that influence the development or course of these disorders.

5. Understand the series of changes in brain cells pass as they progress from healthy neurons to dysfunctional neurons.

6. Characterize the natural history in order to develop outcome measures for clinical trials.

7. Develop animal models.

8. Develop tools for early diagnosis.

9. Develop treatments that improve the symptoms.

10. Develop interventions to arrest the progression and/or restore lost function.

http://www.psp.org/research/researchers/

 

15.10 | Google: Faculty Research Awards program

Google’s mission: organize the world's information and make it universally accessible and useful. The intent of the Google Research Awards is to support cutting-edge research in Computer Science, Engineering, and related fields. Funding: up to $150K for one year (most awards are in the range of $40K-$70K - support for one student for one year). Each funded project will be assigned a Google sponsor. The role of the sponsor is to support the project by discussing research directions, engaging with professors and students, and overseeing collaboration between the project team and Google. Broad research areas of interest to Google:

Economics and market algorithms

Geo/maps

Human-computer interaction

Information retrieval, extraction, and organization

Machine learning and data mining

Machine perception

Machine translation

Mobile

Natural language processing

Networking

Policy and standards

Privacy

Robotics

Security

Social networks

Software engineering

Speech

Structured data and database management

Systems (hardware and software)

http://research.google.com/university/relations/research_awards.html

 

1.11 | Wenner-Gren Foundation: Anthropological research

Post-Ph.D. Research Grants: awarded to individuals holding a Ph.D. or equivalent degree to support individual research projects. Support for basic research in anthropology without preference for any methodology, research location, or subfield. The Foundation particularly welcomes proposals that employ a comparative perspective, can generate innovative approaches or ideas, and/or integrate two or more subfields. Funding: up to $20K.

http://www.wennergren.org/programs/post-phd-research-grants

 

22.11 | Alzheimer’s Drug Discovery Foundation (ADDF): (Proposal due 5.12, LOI due 2 weeks prior)

ADDF funds 4 categories of research; drug discovery and preclinical development, early detection, clinical trials and prevention. ADDF does not fund basic research. ADDF is interested in novel targets and therapeutic approaches for Alzheimer’s Disease (AD), related dementias and cognitive aging. These areas include, but are not limited to: Energy utilization/mitochondria function, insulin sensitivity, protein degradation/autophagy, ApoE function and cholesterol metabolism, vesicular trafficking, inflammatory pathways, synaptic function/morphology, calcium regulation, myelin changes, ischemia and oxidative stress, vascular injury, the blood-brain barrier interface, and translatable biomarkers. ADDF has limited interest in funding anti-amyloid approaches and has limited interest in funding cholinesterase inhibitor programs. Funding priorities: Early identification; Prevention of AD and cognitive decline; Treatment of AD and cognitive aging.

* Preclinical Drug Discovery: ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising preclinical drug discovery and biomarker development programs relevant to AD, other dementias and cognitive aging. ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding averages $150K/year. In some cases, multi-year proposals can be considered.

* Program to Accelerate Clinical Trials: funding for up to $1.5M per application, is offered to increase the number of innovative drugs tested in humans for AD, related dementias and cognitive aging. This program will fund biomarker-based pilot clinical trials for AD and in some cases will also support Phase I safety testing and IND-enabling studies to accelerate new drugs into trials. ADDF is also interested in supporting targeted pharmacological and non pharmacological approaches to prevention and clinical biomarker development programs. Areas of particular interest include:

- Repurposing: testing drugs approved for other indications in AD clinical trials.

- Therapies addressing the following targets: energy utilization/mitochondria function, insulin sensitivity, protein degradation/autophagy, ApoE function and cholesterol metabolism, vesicular trafficking, inflammatory pathways, synaptic function/morphology, calcium regulation, myelin changes, ischemia and oxidative stress, vascular injury and the blood-brain barrier interface.

* ADDF/NIH: financial assistance for relevant NIA and NINDS grant applications that were scored but not funded and fall within the ADDF’s current funding priorities (Application deadline is rolling)

http://www.alzdiscovery.org/research-and-grants/request-for-proposal

 

1.12 | Wenner-Gren Foundation: International Collaborative Anthropological Research Grants

Supports international research collaborations between 2 or more scholars, where the PIs bring different and complementary perspectives, knowledge, and/or skills to the project. PIs must hold a Ph.D. or equivalent in anthropology or a related discipline. Funding: up to $35K.

http://www.wennergren.org/programs/international-collaborative-research-grants

 

30.7.15 | U.S Department of Health and Human Services- BARDA:

* Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

The Biomedical Advanced Research and Development Authority solicits the advanced research and development of medical countermeasures for chemical, biological, radiological, and nuclear agents that threaten the U.S. civilian population. This research is anticipated to advance candidate medical countermeasures towards FDA licensure/approval and consideration for acquisition. Research Areas of Interest (further described in Part I of the announcement):

1. Vaccines (Anthrax)

2. Antitoxins and Therapeutics (Viral hemorrhagic fevers viruses and Anthrax) 

3. Antimicrobial Drugs

4. Radiological and Nuclear Threat Countermeasures  

5. Chemical Threat Countermeasures

6. Diagnostics

Multiple awards of various values will be granted. Deadlines for submission of White Papers for areas 1, 2, 3, 6 are: 30/7/14, 31/10/14, 30/1/15, 30/4/15, 30/7/15. Areas 4 and 5 are open for continuous submission until expiration date, 30/7/15.

https://www.fbo.gov/index?s=opportunity&mode=form&id=53f858046f20978542fe145800cf49a7&tab=core&_cview=1

* Science and Technology Platforms Applied to Medical Countermeasure Development (Innovations)

The program will support technologies and devices aimed at improving medical countermeasures delivery and utilization to enhance the performance, life cycle costs, and operational capacity for existing biodefense medical countermeasures in public health emergency response situations. Additional focus will be placed on supporting the development of medical countermeasures and enabling technologies suitable for use in special populations. Multiple awards of various values will be granted.

https://www.fbo.gov/index?s=opportunity&mode=form&id=59a8bee92eb32ebd33098ec29dacc4c2&tab=core&_cview=1

 

Foreign - all year round:

 

US Department of Defense (DOD) Broad Agency Announcements (BAA):

Air Force: http://www.wpafb.af.mil/library/factsheets/factsheet.asp?id=8127    

Army:       http://www.arl.army.mil/www/default.cfm?page=8 

Office of Naval Research (ONR): http://www.onr.navy.mil/Contracts-Grants/Funding-Opportunities/Broad-Agency-Announcements.aspx

DARPA: http://www.darpa.mil/Opportunities/Solicitations/DARPA_Solicitations.aspx

 

Cancer Research:

 

Solving Kids’ Cancers: The Therapeutic Development Initiative (TDI) - neuroblastoma, pediatric CNS tumors and/or sarcomas

TDI supports clinical testing of promising therapies that may significantly improve treatment for children with pediatric cancer. Final pre-clinical work that is requisite to the submission of a protocol may be considered in certain circumstances. The clinical study must focus on neuroblastoma, pediatric CNS tumors and/or sarcomas. Additional pediatric cancer types included in the study protocol may be acceptable. Funding: $50K - $600K over 2 years

http://solvingkidscancer.org/work/grants

 

Pediatric Low Grade Astrocytoma Foundation (PLGA): Brain Tumor Research Grants

Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of PLGA tumors will be considered. Investigators in the early years of their careers are encouraged to apply. Funding can be awarded over one to three years.

http://akidsbraintumorcure.org/medical-research-on-childhood-brain-tumors/apply-for-a-plga-sponsored-grant/

 

The Gateway for Cancer Research: Treatment Innovator

At The Gateway, our focus is on supporting treatment innovatorsSM who are innovating TODAY - researchers who seek treatments that can help save the lives of today's cancer patients. We encourage interdisciplinary teams and there are legal regulations when an MD needs to be involved.  * Gateway doesn’t fund: basic research and pre-clinical research in animals and no early prevention, detection, retrospective or educational studies.

http://www.demandcurestoday.org/treatment-innovations/funding-process

 

Union for International Cancer Control (UICC): International Cancer Technology Transfer (ICRETT) Fellowships

The objectives of this one month fellowship are to facilitate rapid international transfer of cancer research and clinical technology, to exchange knowledge and enhance skills in basic, clinical, behavioural and epidemiological research and cancer control and prevention and to acquire appropriate clinical management, diagnostic and therapeutic expertise for effective application and use in the home organization upon return. Target candidates: Investigators, public health professionals (who hold at least a BSc or BA), and clinicians,(who are established in oncology practice and hold as a minimum an MD degree). Funding: $3400 for one month.

http://www.uicc.org/programmes/global-education-and-training-initiative-geti/fellowships

 

Liddy Shriver Sarcoma Initiative: Sarcoma Research Grants Program

Sponsors research targeted at finding a cure for sarcoma or attempts to develop more effective treatment regimens than those currently available. Funding: $25K - $250K. The Agency interests include (but are not limited) to:

- understanding the molecular biology of sarcomas

- exploring "molecular targets" for new sarcoma therapies

- studying chromosomal translocations, the oncogenes they generate and their role in sarcoma development

- translational studies

- studying vaccines, monoclonal antibodies, and mTOR inhibitors

- studying the use of nanotechnology in the diagnosis and treatment of sarcomas

- understanding the basis of radiation-induced sarcoma; modeling of the process of metastases

- exploring the differences in the development of sarcomas in children, adolescents, young adults and adults

- research directed at the early detection and diagnosis of sarcoma

http://sarcomahelp.org/sarcoma-research.html

 

James S. McDonnell Foundation: Collaborative Activity Awards supports research in 3 areas: Bridging Brain, Mind, and Behavior; Complex Systems; and Brain Cancer Research. These awards support study panels, research networks or other ways of pushing work on mind/brain forward outside the usual mechanism of investigator-initiated research proposals. The collaborative award process is not used to support meetings, conferences, etc.

www.jsmf.org/apply/collaborative/index.htm

 

Neurological Disorders and NeuroScience:

 

Fox Foundation for Parkinson's Research (MJFF)

Rapid Response Innovation Awards: supports high-risk, high-reward projects with little-to-no existing preliminary data, but with potential to significantly impact on understanding or treatment of PD. Funding: $75K / one year.

Neurotrophic Factors Challenge 2014: one year grants of $125K in the following topics:

- projects aimed at understanding the interactions between neurotrophic factors and alpha-synuclein that could inform future therapeutic strategies.

- novel neurotrophic factors that may be more efficacious than known neurotrophic factors or possess properties, such as brain penetrability, that make them more desirable as potential therapeutics

- efforts to develop noninvasive approaches to deliver neurotrophic factors to the brain

Dyskinesia Challenge 2014: one year grants of $125K for identifying and validating novel and innovative targets for dyskinesia therapies. Pre-clinical studies revealing new pathways, other than the following already explored with MJFF support:

- Serotonergic system: in order to control its inappropriate dopamine release, using partial 5-HT1A/1B agonists

- Overactive glutamatergic system: with an antagonist of mGluR5 or with a selective activation of mGluR4

- Nicotinic receptor subtypes: with selective ligands of the nicotinic acetylcholine receptors

- Altered opioidergic neurotransmission: using mu opioid receptor antagonists

LRRK2 Challenge 2014: one year grants of $125K focused on relevant areas of LRRK2 that can help achieve the following goals:

- Improve biological understanding of LRRK2 function and PD-associated dysfunction to inform effective therapeutic targeting of LRRK2;

- Identify and overcome barriers to developing LRRK2-targeted therapies through engagement with Industry and the LRRK2 therapeutic field.

- Improve clinical understanding of LRRK2 parkinsonism that can inform ultimate therapeutic clinical trials;

- Develop critical LRRK2 research tools that can enable and accelerate the field.

Biospecimen and Tissue Resource: MJFF has supported several pre-clinical and clinical efforts that have generated valuable data, biospecimens and tissue resources for the research community: PD Progression Marker's Initiative / LRRK2 Cohort Consortium / Fox Investigation for New Discovery of Biomarkers / Preclinical Tissue / DATATOP / 24-Hour Biofluids / Rush University Brain Bank / Arizona PD Consortium / PD Smartphone Data Challenge. Researchers may request access to these resources with or without funding requests (up to $250K).

https://www.michaeljfox.org/research/apply-for-grant.html

 

Dana Foundation: Clinical Neuroscience Research Grant Program

Dana is inviting grant proposals for "first in man" studies involving a few patients with devastating brain disease for which there currently is no effective treatment. Funded researchers set up "controlled clinical studies" in a small number of patients with a specific brain disease, based on promising animal studies suggesting that a specific therapy either treated the condition or prevented it from getting worse. In these controlled clinical studies, the new therapy is tested in some of the patients while the other patients continue to receive currently available treatment. Through this process, clinical researchers determine whether the tested new therapy shows initial promise beyond currently available treatment. Grant studies can receive up to $300K over 3 years.

http://www.dana.org/grants/clinical-neuroscience-research/

 

Hereditary Disease Foundation: Research Grants and Postdoctoral Fellowships in Huntington's disease - Letters of Intent

Research projects that will contribute to identifying and understanding the basic defect in Huntington's disease. Areas of interest include trinucleotide expansions, animal models, gene therapy, neurobiology and development of the basal ganglia, cell survival and death, and intercellular signaling in striatal neurons. Budget: Research Grant: $50K for one year, PD Fellowship: $40,500 - $56,000 for one year.

www.hdfoundation.org/funding/grants.php

 

Autism Speaks: Suzanne and Bob Wright Trailblazer Award

Support for a small investigator-initiated high risk/high impact project. Must be highly novel, "out of the box" autism-relevant research that is potentially transformative, paradigm shifting, and/or overcome significant roadblocks in autism research. Funding: $100K for one year.

http://www.autismspeaks.org/science/grants-program

 

Simons Foundation: Autism Research Initiative (SFARI) - Explorer Awards

The program is designed to enable focused experiments to gain a deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches. The foundation seeks investigation at multiple levels, including but not limited to gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. Funding: $60K, for 1 year.

http://sfari.org/funding/grants

 

Other

 

US Army Medical Research and Materiel Command: https://www.usamraa.army.mil/pages/baa_forms/index.cfm

 

Broad Foundation - Broad Medical Research Program: Inflammatory Bowel Disease (IBD) Grants

Funding for up to 2 years for basic or clinical IBD research projects that: are innovative; are in the early stages of exploration; will improve diagnosis, therapy or prevention of IBD in the near future. In addition, BMRP wants to attract scientists who are not currently working in IBD to apply their knowledge, expertise and techniques to IBD research. Interdisciplinary collaboration is strongly encouraged. Requests for funding must be preceded by a brief Letter of Interest.

Special Requests for Proposals:  Differences in IBD incidence between developing and developed countries. BMRP is funding innovative research into the possible reasons for low and high incidence of IBD in different areas of the globe. Proposals should be exploratory in nature or designed as pilot.

http://www.broadmedical.org/

 

Eu. Foundation for the Study of Diabetes (EFSD): Renold Fellowships for Young Scientists

Enables young scientists (age < 35 years (PhD) or < 40 (MD/PhD with clinical training)) to travel and stay up to 3 months at other institutions in order to learn different scientific techniques. Funding: € 8,000.

http://www.europeandiabetesfoundation.org/index.php/ct-menu-item-5

 

Immune Tolerance Network (ITN): Clinical Trials and Assays & Biomarkers in diseases of the immune system - Concept Proposals

ITN is a non-profit, government-funded consortium of researchers working together to establish new treatments for diseases of the immune system. The ITN conducts clinical trials of specialized immune tolerance therapies in the following areas:

* the prevention of organ transplant rejection (in liver, kidney and islet transplantation)

* the treatment of autoimmune diseases (such as type 1 diabetes, multiple sclerosis, lupus and others)

* the prevention and treatment of allergies and asthma

Clinical Trials: ITN accepts applications for novel clinical trials, in the areas of:

Islet Transplantation

Kidney & Liver Transplantation

Autoimmune Diseases

Allergy & Asthma

Assays & Biomarkers: ITN accepts applications for the development of novel tolerance assay or mechanistic studies, for the purposes of establishing new surrogate markers of immune tolerance and investigating the mechanisms of clinical tolerance.

** ITN does NOT accept proposals for non-human or preclinical studies.

www.immunetolerance.org/professionals/proposals/guidelines

 

Institut Mérieux: Research Grants Programme

Institut Merieux’ strategic fields of interest are: infectious diseases, cancer, cardiovascular diseases and food and water safety/nutrition/health.  Mérieux grants are open to basic, clinical-and/or technology-driven research projects. These grants are very flexible and awarded upon examination of a short (3 pages + CV) proposal and a careful scientific evaluation carried out 3 times a year (January, May, October). Two types of Grants are available:

Advanced Mérieux Research Grants: provide €100K - €200K for 2 years and are dedicated to very innovative projects.

Starting Mérieux Research Grants: provide €40K for 2 years and are dedicated to very promising projects that will need further nurturing.

http://www.technion.ac.il/~research/Merieux_Research_Grants_2013.pdf

http://www.institut-merieux.com/uk/politique_grants.php

 

Thrasher Research Fund: Pediatric Research

Supports medical research aimed to improve children's health in a variety of significant pediatric problems, with an emphasis on projects that have the potential to translate into clinically meaningful results within a few years. Both incidence and severity are considered when determining the significance of the proposed topic. Funding: the median award amount is $300K over 3 years.

https://www.thrasherresearch.org/SitePages/al-thrasher-award.aspx

 

Action Duchenne: Research Grants - Pre Preposal

Action Duchenne will consider high quality applications throughout the year. The general research strategy is to increase understanding of Duchenne muscular dystrophy and to support research into, and evaluation of, potential management and treatment strategies. Only proposals which fit the funds' recommendations will be accepted: http://www.technion.ac.il/~research/ACTION_DUCHENNE.pdf

Range of previously funded projects $30K-$175K.

http://www.actionduchenne.org/grantapplications

 

Arnold P. Gold Foundation: Practicing Medicine with Humanism and Humility

Gold Foundation funds unsolicited projects, such as research, lectures, curriculum development, community outreach, cross cultural education, and the publication of literary writings related to the practice of humanistic medicine, which can be self-sustained and replicated. Funding: $250 - $25,000.

http://www.humanism-in-medicine.org/index.php/programs_grants/gold_foundation_programs/grant_requests

 

Cicatricial Alopecia Research Foundation (CARF)

Applications will be accepted from around the world and must serve to further CARF's research goal toward safe, effective treatments, and eventual cure and prevention of cicatricial alopecia. Funding: up to $20,000 for 1-2 years

http://www.carfintl.org/research-grants.php

 

European Molecular Biology Organization (EMBO): Short-term fellowships to advance molecular biology research by helping scientists to visit another laboratory for applying a technique not available in the home laboratory. The fellowships are only provided for exchanges between 2 EMBC member states and are not awarded for exchanges between two laboratories within the same country. The fellowships cover travel plus subsistence of the fellow alone.

http://www.embo.org/funding-awards/fellowships/short-term-fellowships

 

Michelson Grants: non-surgical sterilization products or technologies for use in dogs and cats

Found Animals will provide up to $50 million in multiple, multi-year international grants through the Michelson Grants in Reproductive Biology, for promising research in pursuit of non-surgical sterilization products or technologies for use in dogs and cats. The Foundation seeks proposals for up to $250,000 USD per year for up to 3 years of funding.

http://michelson.foundanimals.org/michelson-grants

 

The Human Frontier Science Program (HSFP): Short-Term Fellowships (2 weeks to 3 months)      International collaboration in interdisciplinary, basic research in the life sciences, to support researchers early in their careers who wish to work in a laboratory in another country, to learn new techniques or to support the establishment of collaborations in a new area of research. A candidate from a non-supporting country (Israel) may apply to work in a research institution in any of the supporting countries: Australia, Austria, Bulgaria, Belgium, Canada, Cyprus (EU part only), Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Korea, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK and USA.  The Fellowships will cover travel and living expenses.  

www.hfsp.org/how/appl_form.php

 

Social Sciences, Education and Humanities:

 

Gerda Henkel Foundation: Small Grants in Historical Humanities

The Foundation funds German and foreign academics in the fields of historical humanities. The following fields are supported in particular: History; Prehistory and Early History; Archaeology; Art History; Historic Islamic Studies; Legal History; History of Science. Funding: up to €15K for the Small grants program. Higher amounts can be requested in the Foundation regular program.

http://www.gerda-henkel-stiftung.de/general_references

 

National Center for Responsible Gaming (NCRG): Seed Grant

This program supports small research projects, in amount of $25K, that can be completed in one year. Funding priorities include:

-Prevention of gambling disorders

-Outcome research on behavioral and pharmacological treatment strategies

-Decision-making and neuroeconomics

-The impact of new gaming technology on gambling and gambling disorders

-Gambling among minorities, especially Native Americans, and issues of health disparities

-Impact of DSM-5 changes in pathological gambling diagnosis

-Biogenetic vulnerabilities to gambling disorders

-Animal models

-Gambling among the elderly and emerging adults.

http://www.ncrg.org/research-center/apply-ncrg-funding/seed-grants

 

Spencer Foundation: Philosophy in Educational Policy and Practice

Funding: up to $40K. Application submission throughout the year..

http://www.spencer.org/content.cfm/philosophy-in-educational-policy--practice-rfp

 

General purpose:

 

DFG: Individual Grants Programme

DFG - the Germany research foundation funds German scientists but Israeli partners can be funded as subcontractors.

http://www.dfg.de/en/research_funding/programmes/individual/index.html

 

Humboldt Foundation and Helmholtz Association of National Research Centres: Helmholtz Research Award

Up to 6 awards annually to internationally acknowledged scientists from abroad in recognition of their achievements in research. Award-winners are invited to carry out research projects of their own choice in the fields of Energy, Earth and Environment, Health, Key Technologies, Structure of matter, Transportation and Space in cooperation with German scientists at one of the 15 member-centres of the Helmholtz Association for periods of 6-12 months. The Award is worth up to EU 75,000. An additional amount of EU 25,000 is made available for the promotion of cooperation in particular with university partners, if the awardee accepts the invitation to undertake research in Germany. Nominations must be made by established scientists at research centres of the Helmholtz Association or cooperating universities.

www.humboldt-foundation.de/en/programme/preise/helmholtz.htm

 

James S. McDonnell Foundation: Collaborative Activity Awards supports research in 3 areas: Bridging Brain, Mind, and Behavior; Complex Systems; and Brain Cancer Research. These awards support study panels, research networks or other ways of pushing work on mind/brain forward outside the usual mechanism of investigator-initiated research proposals. The collaborative award process is not used to support meetings, conferences, etc.

www.jsmf.org/apply/collaborative/index.htm

 

Leverhulme Trust (UK): International Networks

These collaborations enable a British PI to lead a research project where its successful completion is dependent on the participation of overseas institutions. Applications for research on any topic are eligible for support. However, an exception is made for areas of research supported by specialist funding agencies and in particular for medicine. Funding: £125K over 3 years.

http://www.leverhulme.ac.uk/funding/IN/IN.cfm

 

DOD – Office of Naval Research (ONR): Naval International Cooperative Opportunities (NICOP) in Science and Technology Program- White Papers

Mechanism to encourage international science and technology (S&T) cooperation in areas of interest to the Naval Research Enterprise (NRE) by providing seed funding when the Office of Naval Research (ONR) headquarters or other organizations within the NRE commit to out-year program funding. A successful proposal should pull together a team of international and US scientists to address problems of naval S&T interest. A NICOP is not intended to continue projects already underway. When requesting support for scientists who have previously worked together, or are presently collaborating, the proposed project must clearly involve new ideas, new funds and usually the introduction of new participants.

** Due to previous contacts with ONR, Interested applicants are advised to contact the research authority before initiating submission (Robi – 2152, Olga – 1745). 

http://www.onr.navy.mil/Science-Technology/ONR-Global/funding-opportunities/NICOP.aspx

 

DOD – Office of Naval Research (ONR): Collaborative Science Program - international workshops / conferences

The program provides financial support for international workshops and/or conferences in order to achieve specific goals:

1) Planning cooperative science and technology (S&T) programs with researchers in the Naval Research Enterprise (NRE)

2) Identifying and discussing outstanding S&T issues in areas of Department of Navy (DoN) interest

3) Developing long-term relationships between DoN and international science and technology sponsors

4) Maintaining ONRG connectivity with the international scientific community in the focus areas outlined in the Naval Science and Technology (S&T) Strategic Plan.

A formal proposal for financial assistance should be made by the conference organizers or authorized representative at least 12 weeks, but not more than one year, prior to the date of the proposed conference.

** Due to previous contacts with ONR, Interested applicants are advised to contact the research authority before initiating submission (Robi – 2152, Olga – 1745). 

http://www.onr.navy.mil/Science-Technology/ONR-Global/funding-opportunities/conference-support-program.aspx